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Abstract
Understanding the dynamics of a changing world are of great interest to
policy-makers, nonprofit organizations, governments, and businesses since society
largely operates as a system. We develop system models to capture the complexity
of the world in a logical and quantitative manner. Specifically, we use methods
such as network analysis, time series analysis, system dynamics, and Markov
Chains to explore systemic issues. These methods are applied to a socio-technical
system related to public health and sustainability. We will also explore ways
to capture this complexity by first identifying and analyzing the system with
an interdisciplinary perspective then propose a method to integrate system
models.
We begin by identifying the complexity of large-scale systems, such as Research
& Development (R&D) of pharmaceutical treatments. In this project, we utilize
a network representation to investigate collaboration among pharmaceutical
companies and other stakeholders to determine the causes that enable success
in developing a regulatory-approved therapeutic treatment. Secondly, we propose
ii
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an integrated multi-component model to capture the feedback loops that couples
global population growth, environmental sustainability, and health systems.
Finally, we investigate a system dynamics integration of a Markov Chain that
describes migration patterns of the United States with respect to climate change.
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“Everything must be made as simple as possible. But not simpler.”
– Albert Einstein
In a world brimming with complexity, researchers must approach large-
scale societal issues with a systems perspective. This includes socio-technical
systems that consist of human beings and their behavior. A system containing
humans produce chaotic and noisy signals due to the inherent heterogeneity in
human decisions. Much like other natural phenomena, we utilize mathematical
models to understand the main underlying mechanisms that govern these emergent
behaviors. Models that are used to simulate complex systems in engineering
can also be used to observe large-scale socio-technical systems that have many
components and interactions. In this thesis, we will explore innovative ways of
developing an integrated model that captures system-level complexity pertaining
1
CHAPTER 1. INTRODUCTION
to collaboration, sustainability, health, and population dynamics.
It does not take much imagination to characterize our world as a system
with elements interacting with one another. However, systems can be viewed
as “complex.” The complexity of a system arise from the process of multiple
components interacting with each other and its environment [1]. Components
can be defined as individuals, populations, or physical systems that contribute
to the emergent behavior of the system. The most famous example of complexity
is the Lorenz attractor [2], which simulates atmospheric convection based on a
deterministic system of three differential equations with three variables (x,y,
and z). The variables are related to the rate of convection and temperature
variation in two directions. The solution to the Lorenz attractor is chaotic
and noisy which resembles a stochastic process, yet the system is evidently
deterministic when you observe the phase space behavior. Figure 1.1 shows
how such a simple system of three state variables cause complex behaviors
that are commonly observed in the real world.
Similar signals are often observed in social systems where there are several
sources of noise originating from interactions of humans. As a result, these
signals should be isolated to determine how each component contributes to the
noise and behavior of the entire system. Many traditional branches of science,
engineering, and social sciences have observed these elements in isolation with

































Figure 1.1: We recreated the Lorenz Attractor based on [2] to illustrate how
simple systems may cause complex behaviors. The left figure shows the three-
dimensional phase space of the system while the right shows a time series of
the system for the three state variables x,y, and z.
deduce the basic mechanisms governing the emerging behavior and elicit the
expertise of domain experts to develop models that encompass that knowledge.
Furthermore, when one understands the deterministic mechanics underlying
the measured signals, it is possible to infer from the model the causal pathways
in social or health issues.
In the field of public health, the researcher is oftentimes faced with data
that is complex and hard to decode the underlying phenomenon. They can
use advanced machine learning or traditional statistical tools to identify the
variables that are significant and impactful to the observed outcome. After
delineating the factors that cause the behavior, they must seek out expert
3
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opinion and other sources of information that potentially explain the behavior.
Only after this process will the researcher effectively be able to develop an
integrated systems model.
The steps needed to develop an integrated system model are outlined as the
following.
1. identify the system by determining the most relevant components and
interactions between the components,
2. develop a causal loop diagram that classifies components into causal links
and measurable variables,
3. translate the causal loop diagram into a system model,
4. validate the model using empirical data, and
5. perform experiments, sensitivity analysis, and scenario analysis using
the model.
It should be noted that the steps are not necessarily linearly and might
require repeated iteration in order to develop a model that satisfactorily answer
the research question.
With many new methods and tools such as machine learning and artificial
intelligence, predictions have become more accurate and precise. However,
these methods are still considered black-box methods that do not describe the
4
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mechanistic interactions between different components of the system. We can
utilize system dynamics modeling (SDM) to describe the causal relationships
between elements of a complex system. System dynamics allow researchers to
quantify and describe systems at multiple scales which range from industrial
operations to world population growth. SDM has also allowed researchers
across government, industry, and academia to observe emergent behaviors of
complex system systems. System dynamics is considered to be “top-down”
modeling approach to modeling a system.
With the increase of computational power, the ability to simulate systems
from “bottom-up” also became feasible. The most popular method to simulating
a system from the bottom-up is using agent-based models (ABM). This approach
is still state-of-the-art and has been proposed as a straight-forward, and intuitive
method to simulate the bottom-up mechanisms of human behavior. This method
is strong at capturing the heterogeneity of agent behaviors. However, computing
agent-based models may be expensive as well as tedious to parameterize given
the nonlinearities and high-dimensionality. Another bottom-up approach uses
a Markov Chains (MC) to simulate exclusive states of each agent based on
a transitional probability between states. This is different from agent-based
models because Markov chains are based on empirical observations whereas
ABM is based on a decision function is based on theoretical assumptions with
empirical calibration of the agent’s decision function. Both bottom-up methods
5
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have their advantages and drawbacks. ABM offers more information about the
individual-level mechanism while MC offers computational advantages.
Both top-down and bottom-up approaches have real implications on the
causal mechanism of socio-technical systems. In public health, interventions
can also be characterized as bottom-up (e.g. grass-root campaigns, volunteerism)
and top-down (e.g. regulatory policy, taxation). The ability to understand the
system from these two scales is crucial to developing solutions for multifaceted
public health issues since we are able to narrow down the mechanisms that
contribute and exacerbate the systemic problems [3,4]. Furthermore, complex
issues are most likely not exclusively driven by one facet, but the interaction
of multiple scales. For example, how do certain unhealthy behavior cause
regulators to react? One such example of a multifaceted problem is childhood
obesity [5–7] where systems thinking and modeling have contributed to understanding
a complex, multiscale issue. Other public health applications that benefit from
systems thinking include the environmental sustainability and health system
operations [8–10]. All of these aforementioned problems include economic,
demographic, social, and operational aspects that are usually studied in isolation
by siloed disciplines that only study the system from a narrow perspective.
From a modeling standpoint, we can develop a framework that integrates
both bottom-up and top-down models to represent high and low-scales of complex
systems. Furthermore, we can also study one-way and two-way casual interactions
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between components of different scales. Two-way interactions are also known
as feedback loops, and more difficult to model than one-way interactions. An
integrated model couples each component as a distinct “submodel.” It should
be mentioned that in order to capture the relevant complexity of the system,
we need to be able to decompose the system into key features that are relevant
to the scientific question at hand.
1.1 Translating system thinking into system
models
Before we begin modeling, the researcher needs to distill the system into
the relevant parts, we can isolate each subsystem as a separate component and
analyze that particular component as a closed system with fixed inputs from
other systems. By modularizing these components, each subsystem can then
be modeled with different methodologies that are appropriate to the behavior
of that subsystem.
The conception of an integrated systems model begins as a discussion among
domain experts familiar with different aspects of the system in question. In
order to pinpoint the causal structure of the model, collaboration from an interdisciplinary
team of researchers with a priori knowledge about various aspects of the system
is crucial. The discussion among an interdisciplinary group of researchers
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should focus on observed and theoretical causal linkages that affect the systemic
issue in question. One may develop a casual sketch similar to Figure 1.2. The
development of these sketches does not need to be formal since many iterations
are needed in order to synthesize a consensus understanding of the system that



































Figure 1.2: Examples of causal sketches on two different mediums. A systems
approach requires an interdisciplinary discussion. Both diagrams attempts to
capture system that impact population growth.
After the causal sketch is made, one can formalize this diagram as a causal
loop diagram (CLD) [11]. There are other conceptual diagramming languages
such as the systems modeling language (SysML) [12] that formalize systems
thinking into a rigorous and logical framework. Furthermore, visualization
also conveys a level of clarity that is easily accessible to a general audience. The
causal loop diagram is developed based on linking variables that are causally
related. This visualization method is depicted such that variables are considered
nodes, and links are considered causal links. The links are unidirectional




Causal Loop Diagrams can be converted into a system dynamics model.
System dynamics was developed by Jay Forrester [13–15]. System dynamics
was originally meant to invoke systems thinking about a certain issue by endogenizing
all relevant variables [16]. The system dynamics paradigm was originally
created to be interdisciplinary in nature because it is conceptually intuitive.
This allowed researchers without quantitative backgrounds to participate in
the structural formation of the model.
Causal links in the a CLD are classified as positive and negative polarities.
A positive causal link has a positive relationship. When the causal variable
increases the value of the effect variable also increases. Negative polarity
implies that when the cause variable increases, the effect variable decreases.
For example,
Positive Polarity : Fertility Rates ↑ +→ Population size ↑,
Negative Polarity : Mortality Rates ↑ −→ Population size ↓ .
Based on this logic, we can develop a causal loop diagram of a system. A
classic example of a population system is the Lotka-Volterra model of competing
populations, also known as the predator-prey model [17]. In Figure 1.3, we see
the Lotka-Volterra model formalized into a CLD.
9
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Figure 1.3: Lotka-Volterra model with showing the causal relationships
between sheep (prey) and wolf (predator) populations. The polarity is indicated
by the positive and negative next to the arrow heads. The loop in the center is




One of the purposes of causal loop diagrams is to identify feedback loops
within the observed system. These feedback loops come in two variety: balancing
and reinforcing. A balance feedback loop (also called a negative feedback loop)
occurs when a set of variables counter each other. This happens when there is
an inverse “cause and effect” relationship among a set of variables. Balancing
loops tend to stabilize a system and keep the values from increasing or decreasing
uncontrollably.
Reinforcing loops are the opposite of balance loops such that when one
variable changes that influence another variable to change in the same polarity
as the initial variable. This effect is then magnified in the system due to
the circular cause and effect interaction. A good example would be money
invested and the interest that it accrues – as the interest is reinvested into the
principal amount, the interest that is earned in the future increases causing
the principal amount to increase even more than before.
After understanding and diagramming the system, we can deduce the stocks
and flows associated with the CLD by examining which variables accumulate
(i.e., have a memory that is carried over each time step). If the variable is
said to have memory (e.g., population size, a volume of liquid in a container),
we will call this variable a stock. Stocks are adjusted by flows, which are
variables that either increase (inflow) or decreases the stocks (outflow). Flows
can be thought as a rate of change which is mathematically expressed as a
11
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derivative. If we assume stock is y, and xIN and xOUT are respectively inflows
and outflows, then we can mathematically express the stock as an ordinary
differential equation (shown in Equations (1.1) and (1.2)). Variables that are
not considered stock or flow, are called auxiliary variables.
dy(t)
dt
= xIN(t)− xOUT(t) (1.1)
y(t) = y(t0) +
∫ t
t0
xIN(τ)− xOUT(τ) dt (1.2)
We convert the CLD of the Lotka-Volterra model in Figure 1.3 into Figure
1.4.
Once the model has been translated to a system dynamics framework where
the stocks and flows, we will be able to build a mathematical model. The fidelity
of the model relies on the ability to estimate the parameters that describe
observational and experimental data. Different validation techniques are used
to justify the fidelity of the model [18]. Also one should also be concerned about
parameter estimation techniques since the parameter space tend to be highly
nonconvex (one should refer to [19]). There are other nontrivial concerns like
overfitting and optimizing the bias-variance tradeoff with dynamic models.
However, parameter estimation and overfitting will not be the focus of this
thesis. We will mostly focus on the development and integration of systems
12
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Figure 1.4: Lotka-Volterra model represented as a stock and flow. The
stocks variables are wolves and sheep; inflows include wolf births and sheep
births while the outflows include wolf deaths and sheep deaths. Auxiliary
variables include wolf fertility rate, wolf mortality rate, sheep fertility rate,
and sheep mortality rate. The behavior the model is also shown on the right
side. This figure is produced using the Vensim software, which is one of the





1.2 Contributions and Applications of the
Systems Approach
Many projects that are introduced in this thesis are interdisciplinary and
ongoing at the time of writing. The goal of this thesis is to demonstrate how
engineering methods and tools are used to develop integrated models of systemic
issues. The field of engineering, especially civil engineering, has always encompassed
an interdisciplinary approach to tackling problems. In addition, integrated
systems modeling has been used widely in the field of civil engineering to
analyze the coupled effects of infrastructure systems at multiple scales. This
ranges from building systems (e.g. structural, heating, ventilation, and plumbing
systems) to urban systems (e.g. transportation, drainage and sewage, water,
and electrical grid systems). We can translate the same systems modeling tools
into social and public health systems.
In Chapter 2, we present a collaboration network analysis of clinical trials,
and the impact of network structure, actor, and partnerships has on the successful
development of pharmaceutical therapeutics. The work spearheaded by the
Johns Hopkins University Center of Systems Science and Engineering (JHU-
CSSE) and the Massachusetts Institute of Technology Collaborative Initiative
(MIT-CI) to investigate inefficiencies and issues with the process of clinical
trials by including a team of interdisciplinary researchers. In addition to the
14
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quantitative analysis that we presented, field research efforts such as interviews
of stakeholders, round-tables, and ethnographic field visits were carried out in
order for the team to determine the major barriers that hindered the clinical
trials process. Although the regression model used in our network analysis is
not integrated, it must be mentioned that this was the research design was the
synthesis of an intensive deep dive into the complex system of pharmaceutical
clinical trials. The identification of relevant research problems are a necessity
for developing integrated models. The scientific contribution includes using
an interdisciplinary approach that involves actual stakeholder discussions and
field visits to study the clinical trials process. Other studies have investigated
the collaboration network of pharmaceutical companies; however, we captured
multiple types of actors in different stakeholder groups in our network analysis
that ranges from non-profit organizations to academic institutions. We also
make contributions to our understanding of the complexity in the clinical trials
process by observing collaboration on a clinical level.
In Chapter 3 includes work sponsored by the Bill & Melinda Gates Institute
for Population and Reproductive Health that was developed based on a research
effort to understand the global system from a sustainability perspective, as well
as its effect on population dynamics in various income-regions of the world.
Furthermore, we investigated the growing socioeconomic inequality gap within
the populations. This question led to the development of an ambitious integrated,
15
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multi-component model that embodied elements of economics, demography,
climate science, food and nutrition, education, health, and natural resource
studies. These elements are classified into seven submodels in which the structure
was developed based on consultation from various domain experts. We formulated
the casual loop diagrams as well as the equations of motions based on well-
established theories from social sciences and expert consultations. We also
locate the data that would inform the parameter estimation of the model and
propose a heuristic method of calibration of various submodels. In the final
section of the chapter, we will introduce a road-map for a complete integration
of the overall model. The contribution of this model to other integrated assessment
models (IAM) includes an endogenized population submodel with fertility and
mortality rates being affected by other submodels. Furthermore, we attempt
to capture the inequity and disparities of resources, food, and health access
of two socioeconomic groups, “rich” and “poor,” as well as between different
income regions.
Finally, Chapter 4, we introduce a Markov Chain Model embedded into a
system dynamics model that contains a coupled feedback between population
dynamics such as migration, and climate change. This work was based on a
research effort to understand urbanization, public health, and climate change.
This study was funded by the Bloomberg American Health Initiatives (BAHI)
Environmental Challenges Seed Grant to explore public health issues in the
16
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United States related to the environment. The scientific contribution of this
project includes a Markov Chain integration embedded in a system dynamics
model.
Integration can vary case-by-case depending on the application. In Appendix
A, how one can couple two models of different scales. This project is affiliated
with an NSF Hazard-SEES funded project that originated from an interdisciplinary
research effort to develop an integrated model of repeated hazards and infrastructure
resilience. The integrated model utilizes an agent-based model (ABM) and
climate model, and our intermediate model provides an interface for the two
models. We developed the intermediate model using time series analysis and is
mathematically formulated as a distributed-lag regression that predicts indoor
temperature based on outdoor temperature. We demonstrate the utility of the
model against actual data collected from a single house in Baltimore, Maryland,
USA.
1.3 Thesis Summary
In this thesis, we will focus on model identification of complex systems and
the integration of system models to capture complex behaviors. All of these
models were formulated based on an interdisciplinary effort to understand
large-scale, complex issues that overlap into multiple scientific domains. We
17
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specifically look at the research of medical R&D networks, heatwave, and population
and sustainability, and climate-driven migration – all systemic issues that
require the researcher to employ the systems approach. We demonstrate the
system method in the following.
Chapter 2 : Distilling Complexity of Collaboration Networks in Clinical Trials
– Identify complexity of a system and relevant components
Chapter 3 : Multi-component Integration of System Dynamics with Applications
to World Population Growth and Sustainability – Propose a conceptual
framework and formulate a multi-component, integrated model
Chapter 4 : Integrated Markovian Modeling of Climate-driven Migration and
Urbanization in the United States – Integrate a model with a
feedback loop






We investigate the complexity of clinical trials system by identifying a network
of collaborations and the impacts of that network on the success of developing
a drug therapy that is approved by the US Food and Drug Agency (FDA).
The purpose of this chapter is to demonstrate a network characterization of a
complex problem in the medical research field. In the past, business and public
health researchers have looked at the system in parts. However, this system
was studied extensively as a part of an interdisciplinary team to determine
barriers and issues that impact an inefficient system.
19
CHAPTER 2. COLLABORATION NETWORKS IN CLINICAL TRIALS
2.1 Background
Drug research and development (R&D) is an incredibly complex, expensive
undertaking which is prone to failure. Given that on average it may take over
10 years and cost up to 2.6 billion dollars to develop a single approved molecule
[20], drug R&D has become a collective effort. During a drug’s lifespan, it is
common for a spectrum of actors from government, academic, and nonprofit
organizations to pharmaceutical and biotechnology companies to conduct phases
of the basic, preclinical, and clinical research – each contributing towards the
development of a drug that is eventually approved by a regulatory agency.
Furthermore, these actors collaborate to increase their research capabilities
through access to key technologies or specialized knowledge developed and/or
possessed by other actors [21–23]. They also often form vertical alliance networks
where each actor performs a relatively distinct set of activities along the value
chain [24]. More than ever, success or achievement in drug development is
dependent upon these collaborative networks; therefore, it is useful to examine
the collective structure of these collaborative networks and the actors involved
in order to understand the impact of collaborations on the drug R&D process.
One can argue that the system is considered a complex, thus requires researchers
to be able to quantify the complexity and model the attributes of the system
that contribute to success. Network analysis offers a particularly useful set of
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tools for examining both the structure of collaborative networks which exist to
develop drugs as well as the combination of actors who bring them to market.
In this body of literature, researchers examine network “nodes”, i.e., the for-
profit pharmaceutical and biotech companies as well as non-profit academic
and government actors, and the collaborations between them called “links.”
Some studies have examined collaborative networks based on contractual alliances
within the pharmaceutical industry [25,26], while others have studied knowledge
networks which map the dissemination of knowledge via patent citations [27–
30]. Other analyses have considered the interdependence between organizations’
geographical locations [31] and their network position. The goal of these analyses
is to measure the impact of collaborative networks on both the creation and
acquisition of knowledge as well as actual drug development and approval.
Previous research has determined that “cohesion,” a basic network property
used to characterize the structure of networks, impacts the speed and reach of
knowledge transfer between actors which in turn affects productivity. Cohesion
may be thought of as the level of connectivity in a network. Cohesion is measured
by the average path length and global clustering coefficient [29, 32]. Studies
suggest that a low cohesion network, a network with few connections, that has
a low global clustering coefficient results in a larger path distance between
each actor (see Fig. 2.1). In a weakly connected network with low cohesion,
actors would not be able to transfer information efficiently since information
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would likely have to travel through more actors to get to another actor. On
the other hand, a highly cohesive network may reach a point where excess
connections lead to frequent transfers of redundant knowledge which in turn
hinders research productivity [33–35]. This theory is referred to as the “echo
chamber effect” and is supported by previous studies [36,37]. The implication is
that when actors who have similar experience transfer knowledge repetitively
to the same set of actors, they may reduce the marginal production of knowledge














Figure 2.1: The local network of two actors are shown. Both actors are each
connected to four collaborators (other actors in the network). The actor on the
left has a lower cohesion with a local clustering coefficient of 0 which is the
minimum possible value. The actor on the right has a higher local clustering
coefficient of 1 which is the maximum possible value.
In addition to cohesion, existing studies suggest the organizational characteristics
of the actors and their collaborators within the network, such as type of actor
and portfolio (i.e., range of approved and candidate drugs held by an actor), also
play an important role in knowledge acquisition and creation, which contributes
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to higher clinical research output (e.g., the number of drugs approved, research
efficiency, etc.). Research indicates there are advantages to partnering with a
diverse network of collaborators [38–41]. One reason is that collaboration with
a partner that has a uniquely different knowledge base and portfolio allows an
actor to explore domains that were previously outside its own expertise and
potentially difficult or impossible to access without a knowledgeable partner
[22]. Another reason a diverse network may be useful is that a wider knowledge
base might help actors maintain alliance ties [42]. Additionally, research indicates
actors may seek to obtain or exploit innovations developed by partners [23],
but to truly innovate, an actor must be able to combine pre-existing knowledge
with new knowledge that was obtained through collaboration [28]. Therefore,
diverse collaborations through networks comprised of heterogeneous actors
may serve to expand an actor’s knowledge base and/or portfolio which may
be beneficial for drug research and development.
In the present study, we characterize the actors and networks involved in
drug development and examine the extent to which both network cohesion
and diverse collaborations foster the development of new drugs. Rather than
consider the networks formed through patents or contractual alliances, this
is the first study to examine the networks formed when actors collaborate to
run clinical trials in order to bring drugs to market. Using data from both
publically-available and proprietary sources, we followed the shifting collaborations
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of 4,494 actors who sponsored a trial or partnered in the execution of a trial
over a ten-year time period. We found that actors positioned in networks
that have low cohesion tend to fare better in developing drugs that eventually
receive regulatory approval. In other words, actors that collaborated with
partners that were not connected with each other tend to succeed more often
than actors that were more embedded in dense clusters of collaborations. Furthermore,
actors that were less embedded in the network tend to collaborate with a wider
range of partners that have varying expertise in different therapeutic areas.
Therefore, actors are more likely to participate in conducting a clinical trial
for a drug that is later approved when they collaborate with a diverse set of
partners.
2.2 Methodology
2.2.1 Constructing a Clinical Trials Collaboration
Network
We focused our investigation on empirical data from 4,494 organizations
and 18,040 trials extracted from Aggregate Analysis of ClinicalTrial.gov (AACT)
and BioMedTracker Pharma Intelligence databases (See S1 for data collection
and processing methods). Using this data, we were able to construct a two-
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mode affiliation network that included the actors (sponsors and partners) and
clinical trials (distinguished by the national clinical trial (NCT) identifier number).
We then transformed the two-mode affiliation network using a bipartite projection
into a one-mode collaboration network that ranged from January 2006 to January
2016. On a one-mode network, a node represents a single actor, and a link
represents at least one instance of collaboration on a clinical trial between a
pair of actors. We conducted an egocentric analysis on a dynamic, one-mode
collaboration network where the focus is on the organizations or actors over a
period of time. The network representation allows us to observe patterns of
collaborations that facilitate the transfer of knowledge (See S2 of SI).
In order to account for temporal differences, we generated multiple time-
dependent networks to capture the evolution of the network structure over the
considered time period. The network was generated for each month between
January 2006 to January 2016, which resulted in 121 snapshots of the clinical
trials system. A node or link is active at a given snapshot if the respective
actor and collaboration are involved in at least one trial or collaboration during
that month. Based on this network, we developed several metrics to measure
organizational, collaboration, and structural characteristics of actors in the
clinical trials system for each month. We then performed a lagged regression
analysis on our calculated metrics to relate success.
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2.2.2 Network Measures and Actors’ Attributes
We examined the success of each company in terms of research output
and productivity. The metrics that we used are cumulative trial successes
(CTSit) and trial success rate (SRit). Cumulative trials success is defined as
the cumulative number of clinical trials that an actor has been involved in
as a sponsor or collaborator that eventually led to an FDA-approved drug. The
trial success rate is simply the cumulative trial successes divided by the overall
number of trials that an actor has been involved in as a sponsor or collaborator.
The trial success rate captures the organization’s effectiveness in achieving its
research objectives.
We classified the actors into six organization types: academic, government,
nonprofit, industry, hospital system, and large pharmaceutical companies. We
determined the classifications based on additional data gathering efforts using
publicly-available sources and other methods (See S3.1 in SI). This allowed us
to stratify and add in fixed effects to control for the organization type in our
regression. We wanted to distinguish the organizational type because each
actor plays a distinct collaborative role in a clinical trial
For each actor on the network, we computed several node-specific metrics
that quantified expertise, structural, organizational, and collaboration characteristics.
Expertise is determined by designating each actor as having a specialization in
one particular therapeutic area (See S3.2 in SI). Structural characteristics are
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characteristics of the local network of the actor (See S3.3 in SI). Organizational
characteristics are based on the clinical research experience of the actor (See
S3.4 in SI). Collaboration characteristics are based on the relative comparison
of all collaborators versus the observed actor (See S3.5 in SI). In the following
of this section, we will only present selected variables that were used in our
regression. Please refer to the Supplementary Information for a complete
listing and description of all measures.
Tomasello et al. [43] defined the knowledge distance as the Euclidean distance
between organizations i and j at time t. In other economic literature, this is
known as the technological distance [44]. This is formally defined as
KDijt = ∥xjt − xjt∥ =
√∑
d∈D
(xidt − xjdt). (2.1)
where xidt represents an element of the knowledge mix vector xit (see Eq.
1 in S3.4 in SI) with element xidt representing the fraction of clinical trials
conducted in therapeutic area d at time t.
This link-specific metric was meant to compare the differences between the
two firms’ patent portfolios. However, we have adopted this metric to measure
the research differences between a pair of organizations’ portfolios (i.e. the
distribution of trial experience in each therapeutic area). The knowledge distance
is at a maximum (KDijt =
√
2) when actors are concentrated in two exclusively,
different therapeutic areas. When two firms are concentrated in the same
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therapeutic area, the knowledge distance equals to 0 because they are identical
in expertise while a higher KD corresponds with a larger difference.
One of the properties of the Euclidean-based knowledge distance in (B.3) is
that the measure takes into account research diversification of an actor. Let’s
say Actor 1’s portfolio is solely concentrated in Neurology, Actor 2 is solely
concentrated in Urology, and Actor 3 is divided between Oncology and Urology.
In this situation, the knowledge distance between Actor 1 and Actor 2 is larger
than Actor 1 and Actor 3 even despite the fact that both Actor 2 and 3 are in
exclusive research fields relative to Actor 1. This is a well-known property of
Euclidean Distances and fits our case since we are implying that actors that
are more interdisciplinary have more capacity to function in other fields than
specialists.
In our analysis we calculate the mean knowledge distance ⟨KD⟩it for all
incident links to actor i at time t and used it as a variable in our regression.





s.t. i ̸= j
where δit is the number of degrees for actor i at time t.
An actor may decide to adopt two approaches: broadly diversify in different
therapeutic areas (i.e., “jack-of-all-trades”) or specialize in one therapeutic area
(i.e., “master-of-one”). The decision to diversify is usually driven by the size
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of the organizations which determines the economies of scope [45]. Larger
companies tend to diversify more than smaller companies. Furthermore, the
firm must decide whether to collaborate with a jack-of-all-trades actor or a
master-of-one actor that has a deeper specialization in one field.
We quantified research diversification using an entropic measure that measures










where xid is the element of the knowledge mix vector that represents the percentage
of clinical trials experience in disease d. This measure gives us an impression
of the level of interdisciplinary in an organization’s portfolio. We assume that
a company that has completed 0 trials will have an entropy of 0.
From the research diversification that is defined in Equation (B.2), we can
determine mean research diversification of all the neighboring organization of







We were able to capture local cohesion or embeddedness of each actor using
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where Lit represents the number of links between the neighbors of actor i and
δi represents the degree (number of partners) of actor i at time t. The local
clustering coefficient is a good indicator for cohesion since it can show the
extent to which an actor is embedded in the treatment development system.
Local clustering coefficient specifically depicts the connectivity within an actor’s
set of partners.
In our study, we have assumed knowledge is developed through an actor’s
experience which can be quantified as the number of trials conducted in each
therapeutic area (e.g. Neurology). By stratifying knowledge by therapeutic
area, we can determine the relative competencies of each actor in the network
and measure the extent to which their knowledge is concentrated or distributed.
Furthermore, we can designate each actor as an “expert” in a particular field
by observing where most of their trial experience has occurred.
Once we designated each actor as an expert in a particular therapeutic area,
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The variable zidt is the number experts in therapeutic area d ∈ D that actor i
is actively collaborating with at time T . The set D includes all the therapeutic
areas that were defined in the BioMedTracker Pharma Intelligence database.
This entropic measure is commonly used to quantify diversity in many fields
that range from biology to production portfolios [46,47]. This metric examines
the set of partners for each actor and measures the diversity of expertise. In
essence, collaboration diversity characterizes the breadth of expertise in the
actor’s collaboration network. Actor A’s collaboration diversity would be ∼ 0.64
if they worked with 2 experts in neurology and 1 expert in oncology. Actor B
would have a collaboration diversity of ∼ 3 if they conducted 20 trials with 20
different experts all specializing in different therapeutic areas. In this case, we
would say Actor B is more diverse in their collaboration.
2.2.3 Multivariate Regression Analysis
We conducted a regression analysis on two response variables that relate to
research output and productivity: cumulative trial successes and trial success
rate. We ran separate regressions on each response variables with 1, 2, and
5-year lag to capture the delay of knowledge adoption and implementation. In
order to demonstrate the robustness of our regression analysis, we conducted
three separate sets of regression: (i) regression with only the control variables,
and (ii) regression with selected variables, (iii) regression with all measured
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variables (See S4 in SI). The regressions with selected variables are of interest
since they are the most parsimonious models with minimized multicollinearity
and statistically significant variables.
The lagged regression that examined cumulative trial successes (CTSit)
with respect to each actor i at time period t utilizes a negative binomial generalized
linear model. We chose a negative binomial generalized linear model because
the distribution of CTSit was overdispersed. The regression with selected variables
is defined as
log(CTSit) = β0 + β1PrevSucci(t−k) + β2Trialsi(t−k)
+ β3CDi(t−k) + β4⟨KD⟩i(t−k) + β5CCi(t−k)
+ γt + κi + ϵit. (2.5)
The explanatory variables include cumulative trials conducted Trialsi(t−k),
collaboration diversity CDi(t−k), local clustering coefficient CCi(t−k), and mean
knowledge distance ⟨KD⟩i(t−k). We also control the model with a dummy variable,
PrevSucci(t−k), which takes on a value of 1 if the actor has achieved at least one
success before time t − k. The fixed effects for time γt and actor-type κi are
also included in our analysis. The response variable CTSit is lagged k years,
therefore all the covariates corresponding with each actor are at an earlier time
t− k.
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Since the trial success rate SR ranges from 0 to 1, we used a lagged beta
regression. Beta regressions are only used to predict values in the (0,1) range,
therefore a transformation was conducted on SR (see section S4.2 in SI) to
convert the 0 and 1 values to be within the prescribed range. The trial success
rate is defined as the cumulative number of trial successes normalized against
cumulative number of trials. The regression can be shown as
g(SRit) = β0 + β1PrevExpi(t−k) + β2⟨KD⟩i(t−k)
+ β3CCi(t−k) + β4RDi(t−k) + β5⟨RD⟩i(t−k)
+ γt + κi + ϵit. (2.6)
The dummy variable PrevExpi(t−k) takes on binary values and represents whether
the actor has conducted at least 6 trials before time t−k. The variable ⟨KD⟩i(t−k)
measure the mean knowledge distance between the actor and collaborators.
The knowledge distance is a Euclidean distance between two actors’ research
mix vectors. This measure was meant to capture the similarity in knowledge
bases between a pair of actors. Collaboration diversity was not included in (B.6)
because it was not statistically significant for predicting success rate. RDi(t−k)
and ⟨RD⟩i(t−k) quantify research diversification and mean neighbor’s research
diversification, respectively. Similar to collaboration diversity, the research
diversification is an entropic measure that quantifies the breadth of an actor’s
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research activity in each therapeutic areas.
The variables Trialsi(t−k), PrevSucci(t−k), PrevExpi(t−k) and the fixed effects
γt and κi in (2.5) and (B.6) are considered to be the control variables. Robust
checks include conducting regressions on control and all measured variables
for all three time lags. The results of these other models are located in the
supplementary tables in Appendix B.
2.3 Results
The network characteristics of different actors varied among organizational
types. Academic actors tend to have more collaborative links across all organization
types (See Fig. 2.2). This is not surprising since academic centers offer resources
and infrastructure for clinical trials that are not available to other actor-types.
As a result, academic collaborations tend to dominate this collaboration network
in terms of connections. Many principal investigators on clinical trials also
have an academic appointment, even if the trial is sponsored by industry, which
explains the higher count of academic actors.
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Figure 2.2: This chord diagram illustrates the number of collaboration links
between and within the six organizational-types in January 2015. The width










































Cumulative trial successes Trial success rate
Variable 1-year lag 2-year lag 5-year lag 1-year lag 2-year lag 5-year lag
Previous success 2.709∗∗∗ 2.177∗∗∗ 1.285∗∗∗
(0.036) (0.031) (0.046)
Previous experience 0.236∗∗∗ 0.196∗∗∗ 0.077
(0.052) (0.061) (0.105)
Mean knowledge distance −0.330∗∗∗ −0.263∗∗∗ 0.045∗∗ 0.025∗ 0.034∗∗ 0.031∗
(0.016) (0.017) (0.020) (0.014) (0.014) (0.018)
Cumulative trials conducted 0.331∗∗∗ 0.301∗∗∗ 0.236∗∗∗
(0.007) (0.008) (0.015)
Collaboration diversity 0.240∗∗∗ 0.270∗∗∗ 0.269∗∗∗
(0.015) (0.015) (0.021)
Local clustering coefficient −0.075∗∗∗ −0.084∗∗∗ −0.154∗∗∗ −0.037∗∗∗ −0.041∗∗∗ −0.040∗∗
(0.014) (0.014) (0.019) (0.014) (0.015) (0.018)
Research diversification 0.092∗∗∗ 0.103∗∗∗ 0.102∗∗∗
(0.019) (0.020) (0.026)
Mean neighbor research diversification 0.100∗∗∗ 0.115∗∗∗ 0.110∗∗∗
(0.014) (0.014) (0.017)
Table 2.1: The standardized coefficient estimates with standard errors are shown for response variables,
cumulative trial successes and trial success rate. The coefficients for cumulative trial successes is estimated
by the negative binomial regression, while the coefficient estimates of trial success rate are the result of a beta
regression. The statistical significance are indicated as ∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01 and standard errors are in
parenthesis.
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The estimated coefficients for the regressions with selected variables against
cumulative trial successes and trial success rate are listed in Table B.11. For
regressions estimating cumulative trial success, we found that the local clustering
coefficient is a significant indicator with P < 0.01 in most cases and negatively
correlated with research output. This indicates that as an actor ’s network
becomes more cohesive, cumulative trial successes and trial success rate actually
decline. For all the regressions, local clustering coefficient has a significance of
at least P < 0.05 (See SI for a complete listing of effect sizes and P-values).
Collaboration diversity is a significant explanatory variable for cumulative
trial successes with P < 0.01 for all regressions. When we look at trials success
rate, collaboration diversity was only significant for a 5-year lag with P < 0.1,
thus not included in the regression with selected variables.
In our analysis, we noticed that collaboration diversity did not lead to higher
research productivity. In the regressions against success rate SR with all
measured variables, collaboration diversity exhibited a slight negative coefficient
estimate and is not significant in most cases (see Models B1-3, B2-3, B3-3 in SI
Tables 9-11).
Mean knowledge distance is significant for both cumulative trial successes
and trial success rate, which we mentioned as an average measure of portfolio
similarity between an actor and its collaborators. The regression coefficient
value of mean knowledge distance for cumulative trials success is negative for
37











































































































































































































































































































































































































































































































Figure 2.3: (A) Scatterplot of collaboration diversity versus local clustering
coefficient in January 2015. Large pharmaceutical companies that have more
success are distinguished as triangles. The black dashed trend line shows a
linear negative correlation between the clustering coefficient and collaboration
diversity. The color gradient represents cumulative trials successes. This
plot highlights the research performance relative to collaboration diversity and
local clustering coefficient. The gray points represent actors that are active for
that period but have not subsequently participated in a successful clinical trial.
(B) The scatterplot showing the relationships of cumulative trials success with
respect to local clustering coefficient and collaboration for January 2015. Each
organization-type is distinguished by color.
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1 and 2-year lags which suggests that there is a negative correlation between
research output and dyadic similarity, while the mean knowledge distance
has a positive effect at the 5-year lag. In contrast, mean knowledge distance
has a strictly positive impact on trial success rate. Considering collaboration
diversity and mean knowledge distance, we can deduce that actors that collaborate
with a set of partners that are not diverse (more concentrated in one field) but
different from the focal actor’s own expertise will be more likely to succeed.
We found that research diversification and mean neighbor’s research diversification
are significant factors toward the trials success rate with coefficient estimates
being both positive. This suggests that organizations that have diversified
their research activities tend to be more productive. Large pharmaceutical
companies tend to have higher research diversification in our dataset than
other actors.
Based on the regression results, we dove deeper into the relationship between
cohesion and collaboration diversity. In Fig. 2.3A, we noticed there is an inverse
relationship between collaboration diversity and local clustering coefficient which
is indicated by the negative-sloped linear trend line. This indicates that actors
that collaborate more diversely are less embedded in the network. In Fig. 3B,
we examine this finding in more detail. Most actors with lower local clustering
coefficient and higher collaboration diversity tend to be large pharmaceutical
actors that have achieved more research output. Large pharmaceutical companies
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collaborate with many smaller, new market entrants that are not as embedded
in the collaboration network, like biotechnology start-ups [48]. As a result,
large pharmaceutical companies are proficient at absorbing distinct knowledgebases








































































































Figure 2.4: (A) The plot shows the average local clustering coefficient for
dynamically defined successful and unsuccessful actors in the network at each
month. Successful actors are dynamically defined at each time period t as
organizations that will achieve at least one successful trial within the forward
time window ranging from t to t + k, where k is the lag length. Otherwise, the
organizations are characterized as unsuccessful. The standard deviations are
shown as error bars. (B) In the figure, we divide into two static sets: successful
actors (n = 888) and unsuccessful actors (n = 3, 606). The average local
clustering is stratified by actor-type and success for 3 time periods. The error
bars show the 95% confidence interval. (C) Average collaboration diversity of
dynamically defined successful and unsuccessful actors. (D) Same as (B), the
static set of unsuccessful and successful actors’ average collaboration diversity
among different actor-types.
Fig. 2.4A shows the differences in clustering coefficient stratified by successful
and unsuccessful actors as well as organization-types. Successful actors tend
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to have a lower clustering coefficient than their unsuccessful counterparts.
If we focus on organization types in Fig. 2.4B, we will notice that nonprofit
organizations tend to be more embedded in the system, which indicates their
role as a collaboration maker in the system. However, even the successful
nonprofit versus unsuccessful nonprofit organizations have observable differences
in their level of cohesion.
Fig. 2.4C and Fig. 2.4D shows the average collaboration among different
groups of actors that are stratified by success and actor-types. We notice government
and academic actors are the ones with the most collaboration diversity. This is
expected since academic and government institutions are usually responsible
for leading and sponsoring many clinical trials across therapeutic disciplines.
We also notice that successful large pharmaceutical companies are more likely
to seek out a diverse set of actors. This supports existing evidence of biotechnology
companies searching for novelty in knowledge from various scientific communities
[49].
2.4 Discussion
In this analysis, the local clustering coefficient proves to be a significant
variable that is negatively correlated with research output and productivity.
In some instances, betweenness centrality is a significant positive indicator
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of cumulative trial successes, which is generally inversely proportional to the
local clustering coefficient (See Fig. 10 in SI for correlation plot). These two
network metrics demonstrate the importance of network position for innovation.
This finding concurs with the findings of [36], who found that local cohesion
tends to hinder innovation since stakeholders are essentially stuck in an echo
chamber.
We also find that collaboration diversity is related to a higher cumulative
trial success rate and trial success rate. We suggest that there may be two
different reasons why actors that participate in collaborations with diverse
partners are more likely to develop a drug that leads to regulatory approval.
The system shows signs of preferential attachment which occurs when actors
are attracted to other actors that have a demonstrated record of competencies,
which is sometimes known as the “rich-get-richer effect” [21]. Larger pharmaceutical
companies that are historically successful benefit from preferential attachment
such that they attract a wide range of actors with varying therapeutic expertise
and experience. Fig. 2.3 shows this effect, where actors classified as large
pharmaceutical companies tend to have lower clustering coefficients with more
collaboration diversity.
Our findings around mean knowledge distance, demonstrates that actors
must consider more than diversity when choosing collaborators. When two
actors with lower knowledge distance collaborate, they improve research output
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and productivity. This suggests that companies with similar portfolios benefit
from working with one another.
We find that collaboration diversity is negatively correlated with the clustering
coefficient, which indicates that cohesion may not facilitate diverse expertise.
We hypothesize that actors benefit from exposure to diverse ideas and knowledge
through clinical trials collaboration due to the knowledge exchanged with partners
on the peripheries of the system. Large pharmaceutical companies oftentimes
recognize the benefit of knowledge diversity and collaborate with diverse actors
that complement their own competencies. This is reflected in increased instances
of public-private partnerships [50].
Research indicates that collaborating with experts in different fields increases
the actor ’s knowledge base and ability to innovate by combining varying knowledge;
this phenomenon is known as knowledge absorption which has been studied
extensively within the pharmaceutical industry [51, 52]. However, this study
contributes to the body of knowledge by observing this phenomenon within
drug R&D.
Given that large pharmaceutical companies have resources to exploit comparative
advantages of alliances, they are more likely to partner with actors that are
relatively new players that complement their ability and are not yet embedded
in the system [53]. These actors on the peripheries of the network include
smaller biotechnology and pharmaceutical companies that have specialized
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knowledge. By partnering with these outsider actors first, the large pharmaceutical
companies have the ability to claim exclusive rights to their specialized knowledge
before other actors. Therefore, we suspect that when large pharmaceutical
companies collaborate or even acquire these companies, they are successfully
gaining knowledge and resources that contribute to their ability to run successful
trials that obtain regulatory approval.
One limitation to our study is that an approved drug may not necessarily be
indicative to novel knowledge creation, since it may be a marginal improvement
on an existing drug; there are many drugs that are considered “me-too drugs”
which do not necessarily reflect a breakthrough in therapeutic effectiveness.
Given the availability of data, we found it difficult to find a quantitative indication
of true innovation. Although some studies use patents as indicators for innovation,
the pharmaceutical industry files multiple patents for anyone compound that
may have higher marketing potential in order to protect them from generic
drug competition [54]. Nevertheless, we can still argue that a company is
developing knowledge by accumulating clinical research data, personnel, and
patient-base.
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2.5 Conclusion
Our study contributes to the literature by empirical evidence that successful
actors in the treatment development system will seek out diverse collaborators
that are outsiders or new entrants into the market. As a result, successful
actors tend to have lower cohesion in their local network. As the system evolves,
we will inevitably notice a shift of knowledge concentration towards larger
pharmaceutical companies, since there is evidence from this study and others
that they are efficient at finding novel knowledge by searching for diverse
partners. The role of outsider and new actors such as a start-up biotechnology
or life science company will be crucial since the system is moving towards more
cohesion, thus saturating the existing distribution of knowledge.
Applying the network analysis on traditional datasets allowed us to observe
complex features that are not obvious using traditional measures such as firms
and organizations. By observing the clinical trials as a system, we are able to
examine the latent social structure that impacts the drug development process.
We were able to calculate various network metrics on this large dataset. We
further refine the research on pharmaceutical collaborations by focusing on
the collaboration efforts within the clinical phases. Determining the causality
was done by eliciting expert-opinions and synthesizing that knowledge into the
analysis. Furthermore, we contributed by investigated various stakeholder
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groups by characterizing them by actor types. Collaboration between firms
using data regarding strategic alliances has been explored in the previous
literature.
We can extend this work to include drug prices and its relations to the
calculated metrics to observe the correlations between our current variables
and drug prices. Another extension of this work could include analyzing the
global metrics of the entire system and capturing the productivity of the system





Applications to World Population
Growth and Sustainability
In this chapter, we present a multi-component model and the approach
to the integration of the model. This large multi-component model will be
presented in its entirety and proposed methods of integration. In the previous
chapter, we examined how to handle complexity. Once complexity of the system
is characterized quantitatively, we can proceed to model these behaviors as
endogenous processes. We explore ways to build an integrated model that has
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population dynamics as an endogenous variable in the model that is coupled
within a feedback loop.
The intended purpose of this integrated model was four important questions:
(i) how does human population growth impact climate change; (ii) what are the
feedback loop effects between climate change and economic and social systems;
(iii) what is the carrying capacity in terms of food, land, and natural resources
and how does the population dynamics in different income regions behave due
to an ecological overshoot; and (iv) how will inequality be exacerbated due to
these changing factors and what kind of implications does that have on public
health (e.g. disparity of food access during to famines).
This chapter aims at exploring how a large integrated model could be developed
so calibration and testing are manageable. We present the framework of the
integrated model with the relevant equations that correspond with the mechanics
of each submodel, develop a plan of integrations of all model components, and
propose and demonstrate an approach to calibrating each submodel.
3.1 Background
Understanding population growth will be more important than ever. It has
been estimated that 9.7 billion people in 2050 and 11.2 billion people in 2100
by the United Nations [55]. The Intergovernmental Panel on Climate Change
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(IPCC) business-as-usual projections predicting that global mean temperature
will rise more than three degrees Celsius by the end of the century which
will exacerbate issues such as drought and famines [56]. These issues are
important and challenging to model since there are complex mechanisms at
play.
In general, Bayesian population projection models [57, 58] developed by
demographers and statistician have a strong validation but do not account
for feedbacks. Other simpler models without feedback loops were developed
as well to provide policymaker with an easy mathematical identity to provide
policy-makers with a simple tool that is intuitive, such as the IPAT equation
[59].
In 1971, the Club of Rome at the Massachusetts Institute of Technology
commissioned the World 3 model in a publication called Limits to Growth [60].
This model was the first attempt at finding out the anthropogenic impacts and
carrying capacity of the world using an integrated model that endogenized
the population growth rate. However, the World 3 model was criticized as
having parameters that were not based on existing social theories at the time.
Furthermore, World 3 was accused of sensationalizing the existential threat
of anthropogenic effects [61] (please refer to [62] for discussion). Other world
models were developed to compete with World 3 [63–68].
In 1992, Integrated Assessment Models (IAM) were formally introduced
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by William Nordhaus, an ardent critic of World 3, developed the Dynamic
Integrated Climate Change Model (DICE) [69] which eventually won the Nobel
Memorial Prize in Economic Sciences in 2018. DICE introduced a climate
damage function and endogenized economic growth and climate change in a
closed feedback loop. However, DICE does not endogenize population growth
in their model. Other IAMs include [70–72] and also refer to a review of
IAMs [73,74]
Other models that were more theoretical explored growing inequality [75].
Models have also explored ways to integrate different submodels [76,77] within
the main feedback loops.
3.2 Conceptual Framework
The goal of this model is to develop an integrated model of the global population
dynamics with respect to future climate change and other sustainability trends.
The conceptual framework of the model was based on causal diagrams that
were developed from the expert consensus from a variety of disciplines in social
sciences and public health. The model also investigates the growing economic
gap between countries with low, middle, and high economic development that is
documented in the literature. We will refer to the three collections of countries
as income regions. For simplicity, we assumed that countries in each of the
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three income group have identical attributes. Moreover, we also investigate
the growing socioeconomic inequality within each region using economic theory
regarding capital investment and economic growth rates.
The integrated dynamic model consists of seven different components or
submodels that are coupled by feedback loops. This includes the following
• Population
• Health and Education
• Economy (Global and Regional)
• Global Natural Resources
• Global Climate System
• Global Water Resources
• Global Food System
The connections between each submodel are shown as arrows in Figure 3.1,
and these arrows represent the causal links between the variables between
submodels. In our model, we assumed that the population, health and education,
and economy subsystems are regional since components will significantly differ
between nations with different economic statuses. We modeled food consumption
and production, water consumption, climate system, and energy consumption
on a global scale because these resources are oftentimes traded between countries
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with very different levels of development. Furthermore, we are interested in
the relative depletion of resources on a global level resulting from different
consumption from each income region. In order to illustrate the inequalities
between the distribution of global reserve of resources, each income region in





































































Figure 3.1: Overall Model Structure
For each income region, we divided the population into two socioeconomic
groups: “rich” and “poor.” The access to health, education, and food for the
two groups are different resulting in different fertility and mortality rates
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of the population. As a result, we have two identical population subsystem
for each socioeconomic groups in each income region. We defined poor as the
poorest 20% of the population in terms of national income share. This allows
us to distinguish the disparities in resource and service allocations that may
impact the mortality and fertility rates of a population given some assumption
or available data that distinguishes the different socioeconomic groups.
For the health and education submodels, we assumed that these social services
are different for each income region. We also assumed that they are also the
aggregate service volume of each region that within each region the health
and education services are similar. The model also computes the aggregate
economy in each region.
Afeter constructing the causal loop digram and high-level structure, we
can fomulate this model based on the system dynamcis framework, which
traditionally utilizes uses ordinary differential equations (ODE) such that stock








where x is the inflow and z is the outflow. In order to speed up our numerical
computations, we decided to employ difference equations instead of continuous
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= XINt −XOUTt (3.3)





As mentioned before, the population of each of the three income regions is
divided into two socioeconomic subpopulations (rich and poor) with their own
respective fertility and mortality rates. As a result, we have six subpopulations
(3 regions × 2 socioeconomic subpopulation). The motivation for differentiating
these groups is to show that certain changes in social services and food supply
will affect the rate of change in different magnitudes between the two subpopulations
in each income region as well as between the regions. For example, the shortage
of food supply will affect the poorer demographics more since poor populations
typically have less access to food than rich populations due to income constraints.
1However, for the sake of system dynamics convention, we will stick with the continuous
mathematical definition of stocks and flows.
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In each of the subpopulation, we modeled as a series of stocks and flows
which depicts the population size of 8 age-sex groups. We defined four age-
groups: 0-14 years, 15-49 years, 50-64 years, and 65+ years. We also assumed
the traditional 2 sex groups: male and female. Figure 3.3 shows the causal
relationships and stock and flows of each subpopulation. The stock and flow
for each age-sex group are shown in Appendix C.1.Model: C:\Users\Gary Lin\Dropbox\HumanPopDynModel\Model\PopSysDynDiag.mdl View:  Population































































Figure 3.2: Population Subsystem
Total fertility rates are modeled based on Bongaart’s proximate determinants
of fertility, which is a foundational tool for demographers to project the total
fertility rates TFR based on several indicators [78, 79]. The general form for
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Bongaart’s equation is
TFR(t) = CM(t) · CC(t) · CA · CI · TF
= CM(t) · CC(t) · TNM (3.5)
where CM, CC, CA, CI and TF represent the indices for marriage, contraception,
abortion, postpartum infecundity, and total fecundity, respectively. The
abortion index, postpartum infecundity index, and total fecundity TF are assumed
to be fixed constants across time, which implies that the product of these three
indices is constant. The product of these variables is referred as the total
natural marital fertility rate (TNM ) by [78]. We mathematically define
this as TNM = CACITF .
Fertility rates are impacted by the level of female education access which
is consistent with the literature [80], which directly impact CM and CC. We
can also assume that female access to health services will impact the use of
contraceptive CC [81]. Hence,
CC = f(HFkr, EFkr) (3.6)
CM = f(EFkr) (3.7)
The mortality rate DRijkr is associated with the nutrition consumption
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per capita and access to healthcare services, defined as N̂Ckr and HAkr
[82]. The impact on mortality rates varies depending on age, socioeconomic
status, and level development on the country and will be estimated as
DRijkr = f(HAkr, N̂Ckr). (3.8)
Please refer to Section C.1 in Appendix C for complete listing of equations
for the population submodel.
Global Population
Low Income Region Population

















































Middle Income Region Population

















































High Income Region Population

















































Figure 3.3: Population classification
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3.3.2 Health and Education (Regional)
Health and education services are relevant to modeling population dynamics
because they represent direct impacts to fertility and mortality rates. In the
health and education submodel for each region, we assumed that there are
three different levels of health and education systems in the world that corresponds
with the three income region, which means that all countries in a specific
region receive the same level of services. Since we are aggregating the population,
it is fair that the services should be homogeneous.
Health services and education services are defined as stocks which
represent the volume of services in their respective sector (see Figure 3.4). We
quantify this service as the volume of investment that is allocated from the
total economic output. Health services are supposed to represent the number
of physicians, hospitals, and health care systems in a country. The stock of
education services represents the number of schools, universities, and educational
professions in a country.
Both services have a fixed rate of depreciation that is a function of the stock
size. We assumed that the larger the amount of services available, the higher
the depreciation outflow is. As a result, the regions have to invest economic
resources into these subsystems to maintain operations. If the volume of the
economic resource exceeds the depreciation threshold, then the stock of services
will grow, and vice versa.
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Model: C:\Users\Gary Lin\Dropbox\HumanPopDynModel\Model\PopSysDynDiag.mdl View:  Health and Education





















Figure 3.4: Health and Education Submodel
The stock of education directly influences female education attainment which
can be thought of as the average level of education of women. Similarly, the
stocks of health and education services influence the female healthcare access
that relates to family planning and contraceptive services and general health
care access of the population. The variables, female education attainment,
female healthcare access, and general health care access, all feed into the
population submodel.
The equations are located in Section C.2 in Appendix C.
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3.3.3 Economy (Regional and Global)
We modeled the economy based the three income regions with the Solow
growth model. that utilizes four input factors: labor, capital, nonrenewable
resources, and renewable resources to calculate the economic output of each
region. The economic output Y is a Cobb-Douglas production function explicitly
defined as
Y (t) = A(t) · L(t)η1 ·K(t)η2 ·N(t)η3 ·R(t)η4 (3.9)
The technology multiplier which is also know as the total factor productivity
A is assumed to be time variant, and can be modeled as a linear function
to demonstrate exogenous growth with respect to time. The labor, capital,
nonrenewable resources, and renewable resources are input factors, L
and K, have corresponding input production elasticities η1, η2, η3, and η4.
For simplicity, we will assume constant returns to scale, or η1 + η2 + η3 + η4 = 1
for the four input factors. Refer to Appendix C.3 to see how we incorporated
the production function. Typically, the economic output is represented as the
Gross Domestic Product (GDP).
We assumed that the employment-to-working population ratio is fixed
since we are interested in long-term trends. However, the employed labor force
will adjust based on the population size of the working-age groups, which is
defined as the two age-groups between 15-64 years-old. Capital is defined
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Model: C:\Users\Gary Lin\Dropbox\HumanPopDynModel\Model\PopSysDynDiag.mdl View:  Economy





















Figure 3.5: Economic Submodel
in the neoclassical sense in which it includes the real value of machinery,
equipment, and infrastructure. Nonrenewable and renewable resources are
inputs into the economic submodel from the resource submodel. There is a
feedback loop between the factor inputs and consumption rate. Mathematically,
we used the stock levels of nonrenewable and renewable resources to calculate
economic output instead of the resource consumption in order to provide a time-
delay for consumption of resources.
Inequality is modeled based on the conclusion of Thomas Piketty [83] that
the return on capital versus the economic output growth rate is causing socioeconomic
inequality since a fraction of capital ownership belongs to the wealthy. As a
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result, we can mathematically express inequality, Q, as
Q(t) = Ψ · ∆K(t)
∆Y (t)
. (3.10)
We used inequality to determine the poor/rich access to food and healthcare
in each region. Inequality is defined as the share of national income for the
poorest quintile of the population. We define “poor” as the poorest quintile of
the population and the rest as “rich.” We can figure the income per capita for
poor and rich groups based on the Q measure.
For a complete listing of equations in the economic submodel, refer to Section
C.3 in Appendix C.
3.3.4 Global Natural Resources
The natural resources are divided into two types: renewable and nonrenewable
resources. We define nonrenewable resources like fossil fuels and renewable
resources as biomass and timber. It is assumed that the consumption of these
resources is caused by the combined economic activities of Low, Middle, and
High-income regions.
In Figure 3.6, we can see that the consumption of non-renewable and renewable
resources are modeled as outflows. We define economic activities as any activity
that contributes to the Gross Domestic Product (e.g. energy usage, manufacturing,
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Model: C:\Users\Gary\Dropbox\HumanPopDynModel\Model\PopSysDynDiag.mdl View:  Resources













Figure 3.6: Global Natural Resources
mining). There is a balancing feedback between renewable/nonrenewable stocks
and economic growth because these resources also serve as production input
factors for the Solow Growth Model shown in Equation (3.9). The stocks are
meant to represent the reserves of these natural resources in the world. Renewable
resources by definition have a replenishment rate, which is shown as an inflow
in Figure 3.6.
For a complete listing of equations in the resources submodel, refer to Section
C.4 in Appendix C.
3.3.5 Global Climate System
The global climate system is represented by a simplified model of global
temperature and CO2 concentration in the atmosphere. CO2 concentration
increases the radiative forcing in the atmosphere. We assumed the other greenhouse
gases other than CO2 are also contributing to the radiative forcing effects that
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drive temperature change. However, this rate is currently constant since we
assume that the volume of economic activities corresponds to the amount of
CO2.
Model: C:\Users\Gary Lin\Dropbox\HumanPopDynModel\Model\PopSysDynDiag.mdl View:  Climate















Figure 3.7: Climate Change Submodel
We can define climate change by using the IPCC equation that relates radiative
forcingRF with changes in equilibrium surface temperature [56]. The exogenous




= λ ·RF (t) (3.11)
The radiative forcing is calculated using a well-known equation that determines
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the effects of CO2 concentrations in the atmosphere [85]. This relationship is
defined in Equation (3.12) where G and G0 are respectively the concentration
and reference concentration2 of CO2. Radiative forcing from other greenhouse
gases (GHG) is considered by the exogenous parameter RFEXT.
RF (t) = 5.35 · ln G(t)
G0
+RFEXT (3.12)
For a complete listing of equations in the climate system submodel, refer to
Section C.5 in Appendix C.
3.3.6 Global Water Resources
The water resources are modeled as a pooled resource for the whole world.
We assumed that freshwater supply refers to the amount of water accessible
for utilization (e.g. aquifers, lakes). In the global water resources submodel, we
assumed that the reserve of freshwater is a renewable stock with a replenishment
rate. The replenishment rate in our model is assumed as a fixed proportion of
the freshwater stock.
Based on research involving the variability of precipitation due to climate
change, it has been estimated that there could be a net increase in population
that experiences water stresses [56, 86–89]. As a result, we have added an
2The reference concentration of CO2 is commonly equal to the baseline levels of CO2 that is
measured between 1951-1980. This is the standard that NASA uses since these measurements
are determined to be the earliest, most accurate values.
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outflow to the freshwater stock that represents the proportion of the freshwater
stock that is lost due to climate change effects. We have decided that the water
loss due to climate change will be diminishing in relations to temperature. As
a result, we modeled the water loss WL due to climate change as







where CCW represents the proportion of water stocks lost to climate change
effects. This proportion is assumed to be a ratio of the baseline temperature T
versus temperature T at time t with a multiplicative coefficient δW.
We determined that there are three primary uses for water: municipal,
agricultural, and industrial uses. Municipal use refers to water being utilized
by households for average living and drinking purposes. Agricultural uses of
water refer to water utilized in food production of meat and crops. We assume
that the industrial use of water is driven by economic activity. In the current
version, we are only simulating the water shortage effects with regards to the
food supply.
For a complete listing of equations in the water submodel, refer to Section
C.6 in Appendix C.
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Figure 3.8: Water Submodel
3.3.7 Global Food System
In order to simplify the food system so we captured international trade of
food commodities, we examined the food system on a global-level and assumed
that the production of food is dictated by the global demand and supply. We
consider three types of food: fish, livestock, and crops. The inputs factors of
food productions, grazeland, cropland, fisheries, and water, are also modeled
as globally pooled resources.
To consider the disparity between income regions as well as socioeconomic
strata we utilized a partition function that determines the access to food resources
for each income regions and the rich and poor populations of the region.
In order to model the varying demand/production of food versus income,
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Model: C:\Users\Gary Lin\Dropbox\HumanPopDynModel\Model\PopSysDynDiag.mdl View:  Food

























































Figure 3.9: Food Submodel
we utilized the microeconomic concept of income elasticity of demand. The
income elasticity of demand measures the magnitude to which food demand
changes relative to the change in income of a person. We have assumed there
are three different food demand per capita based on the income region since the
demand would be different given higher income regions would have less growth
in demand given an increase in income, and vice versa. This phenomenon is
known as Engel’s Law and has been widely observed [90]. Food demand per
capita is modeled as stocks (shown in Figure 3.9) since we are looking at first-
order changes between income per capita.
For a complete listing of equations in the food submodel, refer to Section C.7
in Appendix C.
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3.4 Data Collection and Processing
In order to estimate the parameters, we must find appropriate indicators
to represent the state variables in our model. We defined state variables as
the output variables that we are observing. These variables vary in units,
therefore, it is important for us to verify the consistency in unit conversions.
We utilized several data sources to inform the model and parameterize the
model coefficients. The data sources ranged from the following.
• Demographic Health Survey, USAID
• World Development Indicators, The World Bank
• International Labour Organization Statistics Database
• United Nations Population Statistics
• World Income Inequality Database, United Nations University
• Global Health Expenditure Database, World Health Organization
• BP Statistical Review of World Energy
3.4.1 Population Submodel Data
Using the World Bank’s classifications of countries into income groups, we
were able to adopt these regions for our model. Please make note that the
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Figure 3.10: Population data for each income region from 1990-2005 based on
the United Nations Population Statistics. We use this information to calibrate
the model.
World Bank has 4 regions: low, middle (lower-middle + upper-middle), and high
income – we decided to combine lower-middle and upper-middle income groups
as one income region. The population for each income region is calculated by
simply summing the population of all the countries in that particular region.
The population size input data for each region are plotted in Figure 3.10.
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3.4.1.1 Estimating Bongaart’s Proximate Determinants
Let’s recall Bongaart’s equation that models the proximate determinants
of fertility which is shown below and in Equation (3.5). These two proximate
determinants are composed of the marriage index CMkr and contraceptive index
CCkr.
TFRkr(t) = CMkr(t) · CCkr(t) · TNM
Based on existing literature, we were able to assume that the “level of women
education attainment” influences the fertility determinant, marriage (CMkr).
Likewise, education attainment and “women’s access to healthcare” is also a
factor that influences the prevalence of contraceptive use (CCkr).
Women education attainment is quantified by As for contraceptive usage
(CMkr),
As mentioned before, we looked at education attainment EFkr and female
health access HFkr as the primary drivers that controls the marriage index
CMkr and contraceptive use CCkr. We assumed a linear functional relationship
(see Equations (3.14) and (3.15)) such that the coefficients αM, αC, βEM, βEC,
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and βHC can be estimated using a linear regression.














In our linear regression, we used country-level data for the input variables,
EFkr and HFkr to predict marriage CCkr and contraceptive-use rate CCkr. The
data that is used to estimate these parameters are extracted from the Demographic
Health Survey (DHS) conducted by USAID.
For our regression analysis, we used marital status of women (Married or
living in union) to represent CFkr and current use of any modern method of
contraception (all women) as CCkr. The independent variable EAFkr is informed
by women with completed secondary education, and HAFkr by the percentage of
women that had their delivery at a health facility (3 years before the survey).
We used 239 observations to estimate CMkr and 222 observations to estimate
CCkr. For both regressions, there were 222 observations spanning 74 countries
and 26 years of surveys from 1990 through 2016. The data and results of the
regression are listed in Table 3.1.
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Coefficient Estimate SE T-stat P-value
αM 0.4514 0.0612 7.3751 <0.001
βEM 0.2022 0.0651 3.1028 0.002
αC 0.4141 0.0657 6.2956 <0.001
βHC 0.1538 0.0407 3.7753 <0.001
βEC 0.3119 0.0805 3.8714 <0.001
Table 3.1: Regression Coefficient Values
3.4.1.2 Estimating Lorenz Curve and distinguishing rich
and poor
Using the data from the World Income Inequality Database from the United
Nations University, we were able to reconstruct the Lorenz curve for each
region. The Lorenz curve is used to determine the population size of the two
socioeconomic groups: rich and poor. We were able to calculate the Lorenz
curve for each income region by aggregating the socioeconomic groups for each
region based on income share percentage. The aggregated Lorenz curve for
each region is calculated for each ten-year interval with the results being shown
in Figure 3.11. We used these values to figure out the distribution of the
population in rich and poor socioeconomic groups. We considered the split
between poor and rich population to be the 20 cumulative percentile of income
share.
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Figure 3.11: Aggregated Lorenz Curve for each income region is shown. The
bottom percentage of the population that has 20 percent of the regional income
is indicated by the orange line. The intersection value is shown by the
number on the right side of the Lorenz curve for each period. We utilized this
information to determine the population size of the two socioeconomic groups.
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3.4.2 Health and Education
The stock of health and education services are impacted by variables directly,
cost and investment. We assumed that a fixed percentage of economic output
(i.e. GDP) in each region goes towards health and educational expenditures,
which we modeled, respectively, as stocks of health and educational services.
Based on the World Health Organization (WHO) and the World Bank, we were
able to estimate these stocks using the expenditures volume.
The health-related variables in the health and education submodel consist
of 3 output variables that are parameterized based on empirical data from the
World Health Organization (WHO): health services (stock variable), female
healthcare access (auxiliary variable), and general healthcare access (auxiliary
variable).
To be consistent with the population submodel, we will use percentage of
children that had their delivery at a health facility (3 years before the survey)
to represent female healthcare access for each income region. We determined
the income region’s health access percentage as the average of all the countries
that belong to that income region. This aggregation method is conducted for
each 5-year interval ranging from 1985-2015. We utilized the percentage of
children that had their delivery at a health facility to as a surrogate measure
for the “rich” socioeconomic group in each region. Additionally, we were given
information on female access to health care for the percentage of children in the
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poorest 20 percent of the population that had their delivery at a health facility
(3 years before the survey), which we used to calculate the health care access
for the “poor” socioeconomic group.
To calibrate the stock of health services, we decided to use health capital
expenditures as a representation for the amount health services (e.g. hospital,
infrastructure) for each income region that is provided by the WHO’s Global
Health Expenditure Database. The health capital expenditures for each income
regions is calculated by aggregating all corresponding countries for each year
ranging from 2000-2015.
We defined general access to healthcare as the ability of the general population
to receive quality healthcare services. As a result, we utilized the Healthcare
Access and Quality Index (HAQI) developed by the Global Burden of Disease
Collaborative Network and downloaded from the Institute for Health Metrics
and Evaluation [82]. The average value of the HAQI measure is used to calibrate
the general health care access for the rich socioeconomic group while the lower
bound of the 95% uncertainty interval is used to calibrate general health care
access for the poor socioeconomic group. This aggregation is done for every 5
year-interval ranging 1990-2015.
There are two variables that we calibrated in this subsystem includes education
services and female access to education. The UNESCO Institute for Statistics
(UIS) database provided information on government expenditures on education
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which we used as a surrogate for educational services. Since the availability of
data for the time-series is sparse, we took the mean of government expenditures
on education for each year ranging from 2011-2014.
Consistent with our regression estimating Bongaart’s Proximate Determinants
((3.15) and (3.14)), we used the percentage of female population age 15+ that
completed secondary education obtained from the Barro-Lee Educational Attainment
Dataset.
3.4.3 Economy
Utilizing data from the World Bank, we were able to directly extract the
aggregate Gross Domestic Product (GDP) of each income region (Low, Middle,
and High-income countries) for each year from 1980 to 2015 to determine economic
output. Capital stock data is extracted from Public and Private Capital
Investment category the Investment and Capital Dataset compiled by the International
Monetary Fund (IMF). We aggregated public and private capital in our analysis
as the total capital investment. The data is used to compute the factor productivity
elasticities in our Solow Growth model formulation for each income region.
Workforce participation rate is collected from the International Labor Organization
(ILO) Database which allowed us to calculate the labor size Labor from population
size data.
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3.4.4 Resources
We collected the data regarding nonrenewable natural resources that are
required for energy production based on BP Statistical Review of World Energy
Dataset. From this dataset, we were able to extract Oil, Coal, and Natural Gas
Consumption, as well as Oil, Coal, and Natural Gas reserves in tonnes, which
we will assume to be nonrenewable resource stock.
The renewable resource stock is assumed to be biomass such as timber
cover. This is extracted from the National Footprint Accounts 2018 Public Data
hosted by the Global Footprint Network. We will use the forest cover area
(acres) as the unit of measurement.
3.4.5 Climate
Data regarding mean global temperature is collected from the US National
Aeronautics and Space Administration (NASA). The World Bank provides data
on the CO2 emission per capita based on income regions.
3.4.6 Water
We used global water reserve estimates from [91]. The study also measures
the global water consumption as well as global water replenishment
rate.
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3.4.7 Food
Using the Food and Agricultural Organization Statistics Database (FAOSTAT),
we were able to calculate the stock for the 3 food types: Fishstock, livestock,
and crops based on the food supply in tonnes at each year. Food consumption,
production, nutrition consumption, and loss were also extracted from
FAO database. Based on the this information, we were able to calculate the
global consumption as well as the regional consumption since the the data was













































Table 3.2: Data Sources
Submodel State Variable Measurement Data Source
Population Population size Pijkr People UN Population Division
Health & Education Health services HSr Health Capital Expenditures (current USD) WHO Global Health Expenditures Database
Health & Education Female healthcare access HFFkr Percentage of children that had their delivery at a health facility (3 years before survey) UNICEF Maternal and Newborn Health Coverage Database
Health & Education General healthcare access HAFkr Healthcare access and quality index (HAQI) Institute for Health Metrics and Evaluation
Health & Education Education services ESr government expenditures on education (current USD) UNESCO Institute for Statistics (UIS) Database
Health & Education Female education attainment EFr percentage of female population age 15+ that completed secondary education Barro-Lee Educational Attainment Dataset
Economic Inequality Qr Bottom percentage of the population that shares 20% of national income UNU World Income Inequality Database
Economic Economic Output Yr Gross Domestic Product (current USD) World Bank Databank
Economic Capital Kr Public and Private Capital Investment (current USD) IMF Investment and Capital Dataset
Economic Labor Lr Labor Force Participation Rate (current USD) ILOSTAT Dataset
Resources Nonrenewable Resources N Coal, Natural Gas, and Oil (tonnes and barrels) BP Statistics Dataset
Resources Renewable Resources R Forest Cover (acre) GFN National Footprint Accounts 2018 Public Data
Climate Mean global temperature T Mean global temperature (Celsius) NASA Open Data
Climate CO2 Emission per capita Ĝb CO2 emission per capita (ton per capita per year) World Bank Databank
Food Livestock Production FPMEAT Livestock Production (tonnes) FAOSTAT Commodity Balance
Food Fish Production FPFISH Fish Production (tonnes) FAOSTAT Commodity Balance
Food Crop Production FPCROP Crop Production (tonnes) FAOSTAT Commodity Balance
Food Livestock Consumption FCMEAT Livestock Consumption (tonnes) FAOSTAT Commodity Balance
Food Fish Consumption FCFISH Fish Consumption (tonnes) FAOSTAT Commodity Balance
Food Crop Consumption FCCROP Crop Consumption (tonnes) FAOSTAT Commodity Balance
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3.5 Model Integration
The overall structure of the model is divided into a multi-component model
in R. The main relationships between each submodel outlined in the previous
section are explicitly structured in the R code as shown in Figure 3.13, such that
a submodel is represented as a separate component of the model. Specifically,
each submodel is defined as a separate function in R.
Certain regional submodels have region-specific outputs that are combined
by aggregation functions to become one global-scale variable that acts as a
component input into global-scale submodels. On the other hand, some of
the global-scale components have global-scale outputs that are reallocated to
each region by a partition function. The modularity of each component allows
us tremendous flexibility in increasing the complexity of mechanics in each
submodel, as well as the expansion of the model in future iterations.
In order to speed up the simulation, all differential equations were converted
to difference equations. In essence, we assumed
dY(t)
dt
≈ Y(t+ 1)−Y(t) (3.16)
Each computational run is approximately one second. This much faster than
using a numerical solver for solving ordinary differential equations. We assumed
a time step of one year and ran the model from the year 1980 to 2080. The
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Figure 3.12: Component Diagram of the entire model. The aggregation
functions are represented as Σ and the partition functions are represented as
P . The submodels (component) of the model are depicted as solid squares. The
input and output variables for each component are shown as the arrows. The
variables are generalized as Pk = population size, Ek = economic output, Fk =
food/nutrition consumption, Rk = nonrenewable/renewable resources, HEk =
health and education access, and T = global temperature.
initial conditions were informed by external data sources which were described
in Section 3.4.
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3.6 Submodel Parameter Estimation
In order to solve our problem, we utlized the least-squares ftting to estimate
our parameters based on points from 1980 to 2015, which were collected and
outlined in Section 3.4. Lets say we have N number of state variables (output
variables) in our model and T number of observed poionts. We have empirical
data with one realization for each variable yit and can simulate the data using
the integrated model ŷit. We can then define a cost function as the sum of











We can generalized our integrated nonlinear model as
ŷit = f(xijt, aij) (3.18)
where xijt are system input variables aij are coefficients corresponding each
system variables (assuming there is a coefficient corresponding with each input
variable).
We also know the minimum (aMINij ) and maximum possible values (amaxij ) of
each coefficient values. This allow us to estimate the parameters using the
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yit − f(xijt, aijt)
wi
)2
s.t. aminij ≤ aij ≤ amaxij (3.19)
In order to reduce the number of parameters that need to be calibrated
by optimization, we have elected to calibrate the submodel individually. We
assumed the nonlinear least-squares problem (3.19). The parameterization
was carried out using the GA package in R. The GA library includes several
metaheuristic genetic algorithm solvers that allow the user to easily define the
cost function (error function) and the parameters.
Based on the structure of our model, the submodel components are able to
be isolated such that the parameters in each submodel are solved individually
with endogenous inputs into each submodel being substituted by exogenous
inputs. We demonstrate the parameter estimation process in Figure 3.13.
We utilized the gaisl function in the library GA to calibrate the coefficients
and fit our difference equation model. The computation was conducted using
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Figure 3.13: Whole Model versus Submodel Calibration Flow Chart.
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3.6.1 Calibrating Health and Education Submodel
In this section, we demonstrate how the parameters of the health and education
submodel for low-income countries are computed using the proposed approach
in Section 3.6. The equations for the system are the following.
Change in health services :
dHSt
dt
= HGt −HDt (3.20)
Change in education services :
dESt
dt
= EGt − EDt (3.21)
Growth in health services :HGt = ΛHr ·∆Yt (3.22)
Growth in education services :EGt = ΛEr ·∆Yt (3.23)
Health service depreciation :HDt = ζHr ·HSt (3.24)
Education service depreciation :EDt = ζCr · ESt (3.25)














+ χHA3 · Ŷ POORt (3.28)
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+ ψHA3 · Ŷ RICHt (3.29)
There are only two stock variables: HSt and ESt. The variable definition are
not important for this exercise but are listed in Table C.2 in Appendix C.
We have data yit for all the state variables , which are defined in the following
vector with N = 10 elements.
yit =
(







The simulated values X̂it are the following.
ŷit =
(







We also assumed that each state variables has a corresponding weight.
wi = (W1,W2, . . . ,W10) (3.32)
We have M = 14 parameters, which will be the decision variables that we
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are optimizing to minimize the least-square error shown in Equation (3.17).
pj = {ΛHr,ΛE, ζH, ζC, χHF1, χHF2, χEF1, χEF2, χHA1, χHA2, χHA3, ψHA1, ψHA2, ψHA3}
(3.33)










































































s.t. pminj ≤ pj ≤ pmaxj j = 1, . . . , 14. (3.37)
Using the island genetic algorithm, we were able to fit the health and education
state variables for low-income countries. Figures 3.6.1, 3.6.1, 3.6.1, 3.6.1, 3.6.1,
and 3.6.1 shows the predicted fit versus the actual fit.
In order to illustrate the actual trendlines of the state variables, we elected
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Figure 3.14: General Health Access of Poor Population in Low Income Region.































































Figure 3.15: General Health Access of Rich Population in Low Income Region.
Target series represent the a smoothed version of actual data points.
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Figure 3.16: Health Services in Low Income Region. Target series represent



























































Figure 3.17: Female Health Access in Low Income Region. Target series
represent the a smoothed version of actual data points.
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Figure 3.18: Education Services in Low Income Region. Target series represent


























































Figure 3.19: Female Education Attainment in Low Income Region. Target
series represent the a smoothed version of actual data points.
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to use a smoothed, denoised series instead of actual raw data of the state
variables. It is also noticeable that the simulated results are very noisy. We did
not smooth out the exogenous input data of the health and education submodel.
The noise in the simulated values corresponds to the actual economic output
and income per capita data, which are defined as aggregate Gross Domestic
Product (GDP) and GDP per capita of all the countries in the low-income region,
respectively. We also calibrated the health and education submodel for middle-
income and high-income regions (see Appendix D).
3.7 Conclusion
The main contribution of this work is to present an endogenized population
submodel that is fully integrated into a sustainability and health model. Other
contributions include the ability to model disparities of food and healthcare
access between socioeconomic groups and income regions. Since resource scarcity
typically affects the poorer populations more, it is important to include these
features into the equations of motions that govern global population dynamics.
The results from the submodel calibration show that it is possible to calibrate
all submodels that were presented. Once the parameters of each submodel
are all estimated, we can proceed to integrate the submodels into the overall
model with endogenous feedback. To achieve full integration, we propose a
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methodology that would make it possible to interface all the submodels and
observe the multiple feedback loops that control the behavior of the system.
The second step would require us to re-estimate all the parameters in the whole




of Climate-driven Migration and
Urbanization in the United
States
The motivation for this chapter is to demonstrate the use of Markov Chains
for origin and destination data of human mobility. Furthermore, we show how
we integrated the Markov Chain model with a system dynamics model that
features a feedback loop that encompasses the global climate and population
dynamics of the United States. The chapter first presents the background, then
lays out the model formulation. Afterward, we show results from the model
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based on parameterization from empirical data.
4.1 Background
Urbanization is a phenomenon that is occurring all over the world as more
people are finding better economic, social, and housing opportunities in cities
[93]. The attracting forces of migration are commonly known as pull factors.
Besides the pull factors that attract people to cities, there are also push factors,
such as the environmental changes and economic uncertainty, that force people
to leave their existing residence to pursue stability for themselves and their
families. However, given the exacerbation of global climate change in recent
times, environmental push factors will become a greater influence on mobility
in the United States as sea-level rise displace residents in low altitude regions
near the coast and impacts on agricultural production and rural economy motivate
residents to pursue opportunities in cities [94].
Given sea-level rise (SLR) projections for the next hundred years range
from 0.3 meters to 2.0 meters, the United States must consider the possibility
of permanent migration of coastal inhabitants and prepare for adaptation to
climate change. Depending on the magnitude of SLR, it has been estimated
that 4.2 million to 13.1 million people could be at risk of inundation [95].
Some have already examined the internal migration flows caused by climate
95
CHAPTER 4. US MIGRATION MODEL
change that may occur if the US does not take steps in reinforcing its current
infrastructure to protect the affected regions [96]. It is important to model
these relationships in order to quantify the cost and damages that will be
incurred.
With increased migration flows into inland areas, existing cities will face
an additional burden on their infrastructure and social services. Furthermore,
increased urbanization also has environmental implications, such as faster
urban development that contributes to global warming (i.e. heat island effect).
Faster urbanization may also accelerate industrialization that contributes to
greenhouse gas emissions. However, other studies have shown that urbanization
may lead to lower emission per capita of greenhouse gases (GHG) [97]. The
United States accounts for 15% of all CO2 emissions in 2014 [98]. That contribution
to emissions will drive the pace of global warming. Hence, urbanization is a
systemic issue that contains reinforcing feedback loops that couples population
dynamics and climate change.
Other other frameworks have explored the feedback between migration and
climate change by looking at the epidemiological implications of climate change
impacts on infectious diseases and migration [99]. System dynamics set up an
appropriate mathematical structure to model migration [100].
We explore the internal migration patterns of the United States based on
tax exemption data from the United States Internal Revenue Service (IRS)
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and demographic data from the Census Bureau. The study is carried out using
as a system dynamics model that embeds a Markov Chain to determine the
destination probability of internal migration.
4.2 Data
Internal migration flows were extracted from the US Internal Revenue Service’s
Statistics of Income (SOI), and county population size was extracted from the
United States Census Bureau. We are using the 2013 Urban-Rural Classification
Scheme from the National Center of Health of Statistics (NCHS) to designate
the extent to which a county is urban or rural. We assumed counties are
urban if they contain a large metropolitan statistical area (MSA) with at least
1 million people or more, or if they are a fringe county of MSA with 1 million
or more people. The coastal areas were designated based on their geographic
proximity to the Atlantic Ocean, Pacific Ocean, and the Gulf of Mexico. The list
of coastal counties was obtained also obtained from the US Census Bureau.
Given these assumptions, we were able to aggregate the populations of all
counties in the US into 4 different groups:
• Coastal, Urban – This includes urban areas that border the Atlantic
Ocean, Pacific Ocean, or the Gulf of Mexico.
• Non-coastal, Urban – Urban areas that are not considered coastal.
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• Coastal, Rural – Rural areas along aforementioned bodies of water.
• Non-coastal, Rural – Rural areas that are not considered coastal.
Coastal−Rural Coastal−Urban Noncoastal−Rural Noncoastal−Urban
Figure 4.1: We classified each county into four groups which are shown on the
map.
The initial parameters of the model such as population size and migration
flows can be determined using the data from the NCHS and US Census Bureau.
We used population estimates from the US Census Bureau to calculate the
population change rate of each aggregate region. Specifically, we collected data
on county-level birth, death, and international migration rates and used that
information to calculate and parameterize the growth rate of each population
group. All data and projections were processed in the R statistical environment.
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Migration patterns were extracted from the Statistics of Income (SOI) dataset
created by the Internal Revenue Service (IRS). This dataset includes year-
to-year address changes from individual income tax statements. Since the
majority of residents have to file their income taxes, internal migration patterns
are reasonably represented in the SOI dataset. Nevertheless, there are limitations
in the SOI dataset; seasonal and return migration are also captured which
makes it difficult to distinguish from long-term and forced migration that is
caused by economic and environmental events.
Migration flow for 2015-2016 is shown in Figure 4.2. We can see that the
majority of internal migration takes place within the aggregate regions which
probably reflects a short-distance move. Migration within aggregate regions
also includes inter-county migration. We are mostly interested in the rural-
urban migration flows. The distribution of year-to-year migration is fairly
consistent from 2011-2016. The migration flows for 2015-2016 can be better
represented in the chord diagram in Fig. 4.3 where the width of links represents
the volume size of flow.
4.3 Motivation and Background
We developed a computational model that focuses on the theoretical relationship
between migration flow and climate-driven events. We want to know how many
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Figure 4.2: The four plots show the 2012-2016 internal mobility (county-to-
county flows) in the United States for our aggregate groups. For clarification,
the top right plot labeled “Coastal-Urban” represent the migration from
coastal, urban counties, and the four destinations are color coded. In
that particular plot, the highest migration flow is within the coastal-urban
aggregate region (i.e., coastal-urban to coastal-urban) which is represented by
the green line. This is based on the IRS Statistics of Income (SOI) dataset.
coastal residents will move after their house is displaced by sea-level rise. In
rural areas, we want to know how many residents’ livelihoods are threatened
due to climate change impacts on agricultural production, and the impact that
will have on rural-to-urban migration. The combined effect of these two events
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Figure 4.3: The inter-regional migration flows are shown here where the
widths are scaled based on migration size. The tick marks represent 1000
people. We do not include migration within regions, which is the majority of
internal migration in the US.
will impact urbanization of inland cities.
The implementation includes a Markov Chain model with integrated feedback
loops as a proof-of-concept that capture the dynamics that drive climate change
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and urbanization. The structure of our model is shown in Figure 4.4. The four
groups that were mentioned in the previous section are utilized in our model.
Based on the data collected, we were able to calculate the initial conditions and
parameters associated with population and migration dynamics.
We included two important feedback loops that connect climate change and
urbanization. The first feedback loop includes migration from coastal to non-
coastal areas due to inundation from sea-level rise. We’ve also included a
second feedback loop that connects agricultural production that is sensitive
to climate conditions with migration flows from rural-to-urban regions. Based
on the IRS SOI data, we were able to delineate future migration trends based
on current migration patterns. However, in a more extreme climate change
context, we can argue that the two feedback loops included in our model will
magnify the aforementioned population movements towards safer regions, i.e.,
non-coastal urban regions.
The computational model is developed based on a Markov Chain with feedback
that is commonly used in discrete-time simulations of the migration system.
The system of equations that govern the dynamics of our computational model
is shown in the next section. The model is implemented in the R environment
as a system of difference equations.
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Figure 4.4: The conceptual causal links of our computational model is shown
along with the two primary feedback loops. Urbanization and its impact on
GHG emissions will impact climate conditions. Subsequently, climate-sensitive
events such as sea-level rise (blue arrows) and agricultural yield (green arrows)
will push residents in these vulnerable regions to move to a more stable region
in the US. The dotted arrows represent typical migration patterns that occur
in a “business-as-usual” situation.
4.4 Markov Chain Integration in a System
Dynamics Model
We define the population of the four region i where i ∈
{
Coastal-Rural =
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t+ 1 as the following




where Pi is the population, Bi is the birth count, Di is the death count, Mji is
the migration flow from region j to region i within the US, and Gi represent net
migration from other countries into the US. We can also represent variables Bi,
Di, Mji, and Gi as rates instead of count variables. The birth, death, internal
migration, and international migration rates can respectively be represented
by bi, di, mji and gi. Therefore, the population of each region can be recast as








The variable φi represent the growth rate of each region minus the internal
migration. We used a linear model to forecast the population growth rate φi for
each region.
Given the dynamics of Equation (4.2), we can model the population size of
each region as a Markov Chain Model (MCM). The exogenous inputs, i.e., the
growth rate is defined as a diagonal vector Φ(t) = diag(φ1(t), . . . , φ4(t)) where
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the elements correspond with the rate of natural increase plus international
net migration for each region. Based on the birth, death, and immigration
rates that were calculated from the US Census Bureau estimates from 2011-
2016, we were able to linearly project the population change rate with respect
to time for all 4 regions. Hence, births, deaths and international migration are
considered to be exogenous in our model. The state (population) of the system
at time t is stored in the vector p(t) = [P1(t), . . . , P4(t)]T . Our population can be
modeled as
p(t+ 1) = p(t)Φ(t) + p(t)M(t). (4.3)
The transition matrix M is the collection of transition probabilities for internal
migration between two regions, and the dynamics of the transition probabilities
is of great interest to us. Internal migration by definition is a closed system
where a resident’s decision to stay within the same region or move to one of
the other 3 regions are mutually exclusive and exhaustive events. In other
words,
∑
j Pr(Xt+1 = live in region j|Xt = live in region i) = 1. Therefore, the
internal migration transition matrix M must be a stochastic matrix where
all the elements in each row sum up to 1. We can maintain the stochastic
properties while altering the transition probabilities with the following formulation,
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M(t) = M0 +MS(t)∆S(t) +MA(t)Γ(t). (4.4)
The scaler coefficients ∆S and Γ represent the sea-level and agricultural
production impacts on migration, respectively. M0 is the initial transition
matrix that is parameterized with data from the IRS SOI dataset for migration
in 2011-2012. We calculate the initial transition probability of internal migration






































where the elements Mij
Pi
are calculated based on the proportion of the population
in region i migrating to region j.
The matrix MS adjusts the initial transition probabilities of coastal regions
in M0 based on the sea-level while maintaining the stochastic properties of M.
Specifically, this matrix adjusts the migration from the non-coastal to coastal
regions. We weighted the matrix MS so non-coastal, urban areas receive more
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migration. This matrix is defined as the following.
MS =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
−1.5 −1.5 1 2
−1.5 −1.5 1 2
0 0 0 0
0 0 0 0
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
(4.6)
The matrix MA adjusts the transition probabilities of M0 with respect to
agricultural output. Specifically, MA represents the change in the migration
probability from rural to urban regions due to the adverse impacts of climate
change on agriculture-based economies in rural counties.
MA =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
−1 1 −1 1
0 0 0 0
−1 1 −1 1
0 0 0 0
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
(4.7)
The element values of MS and MA are based on theoretical effects of sea-
level displacement and agricultural production. These are assumed values
that meant represent the effect-size on the transition probabilities of internal
migration by sea-level rise and agricultural production.
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The scaler coefficients that adjust the magnitude of migration due to sea-
level rise and agriculture in Equation (4.4), MS and MA, are calculated as





The coefficients α and β are parameters that will have to be adjusted during
our scenario runs to reflect different impact magnitudes of sea-level S and
agricultural productionA. The equations that govern the sea-level and agricultural
production trends are
S(t+ 1) = S(t) + αT (t) (4.10)
A(t+ 1) = A(t)− βT (t) (4.11)
where the coefficients α and β represent the change rate of sea-level rise and
agricultural production with respect to mean temperature (i.e., climate). We
are assuming that agricultural production is inversely correlated to climate.
Studies have suggested that climate change has caused more incidents of extreme
weather events that may cause droughts [101].
We also based our temperature model, on a simplified set of equations that
model relationship between CO2 emission and climate. The CO2 that is emitted
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will cause an increase in radiative forcing FCO2 of CO2.
The equation for temperature can be represented as
T (t+ 1) = T (t) + ∆T (t) (4.12)
where the first-order temperature change ∆T is defined as
∆T (t) = λFCO2(t) + FOTHER(t). (4.13)
We also include radiative forcing from other greenhouse gases (GHG) as FOTHER.
We model the CO2 radiative forcing FCO2 as a function of total carbon dioxide
emission:






Finally, the total CO2 is simply the sum of the emission rate from all four
regions. The constant C0 represents the reference (initial) carbon dioxide concentration.
We assume the emission rate per capita Ĉi varies between the regions and is




ĈiPi(t) + EC(t) (4.15)
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4.5 Migration Results
The model presented here is simply a framework for an integrated model.
We ran the model with the population data collected from the IRS and US
Census Bureau to simulate the potential trajectory. As mentioned before, the
birth, death, and international migration rates are considered exogenous, which
led to a similar projection with the US Census Bureau (see Figure 4.5). We
parameterized a linear growth model based on birth, death, and international













































































● ●Our Model US Census Projection
Figure 4.5: Comparison of our working model and the United States Census
Bureau projections up to year 2060.
The population trends from 2011-2016 for each region are shown in Figure
4.6, and this captures the hypothesized relationship between climate change
and migration. We can see that the non-coastal, urban region is growing faster
than any other region. This is consistent with our assumptions that people will
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migrate towards cities that are inland.
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The results presented in Section 4.5 demonstrate one possible trajectory for
population dynamics. From the results, we see that it is possible to capture
long-term trends using a dynamic model that have other factors with relevant
feedback. Since climate change effects are a nonstationary process, we must
rely on careful calibration of feedback models to understand effects on health
systems, population mobility and growth, and greenhouse gas emission rate
increase. We used theoretical relationships of temperature with agricultural
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production and sea-level rise to estimate a possible effect on internal migration.
The main contribution of this model is an integrated system dynamics model
that embeds a Markovian process. We do not consider pull-factors, such as
economic opportunity, which may alter future migration patterns, but this may
be difficult to include in our model since this requires additional assumptions
based on individual decision-making. One may integrate individual-level, agent-
based decision functions to this model, but this will inevitably increase the
computational requirements. We introduce a Markov Process which is based
on empirical probabilities.
At the moment, the model only includes the aggregate population dynamics.
The spatial scale could be refined later if we decide to increase the granularity
of the model to include county-level systems. At the current spatial scale of
the model, it would be difficult to model infrastructure, social, and economic
systems that might influence internal migration. We can increase the granularity
of the model to include county-level dynamics. This would significantly increase
the dimensionality of the problem. The model can be refined by including
the variability of sea-level rise for each coastal region. Also, we can extend
the model to include geographic differences between each coastline community




The work that was presented in Chapters 2, 3, and 4 are just a few examples
of how system modeling could be integrated to provide a richer understanding
of how the system works as the sum of its parts. The need for integrated
climate models has long been discussed due to the complexity of the interconnectivity
between the natural environment and human systems. Although it is commonly
understood that “all models are wrong,” it is still difficult to understand the
true system without attempting to model the interactions of the subsystems
that make up the entire system.
Furthermore, we see that sustainability have a direct impact on public
health since these issues are far from being mutually exclusive topics. In a
world that has finite resources, nutritional intake of poorer populations will
be restricted and put the health of millions in jeopardy as resources become
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scarce. Social consequences of growing inequality will also impact poorer populations
and their access to basic healthcare services. This is especially true in low-
income countries that have yet or are in the midst of transitioning economically
into middle-income countries. We show in Chapter3 that an integrated model
will allow researchers to understand the effects on population growth from a
systems perspective due to the endogeneity of population submodel.
Even in wealthier countries, such as the United States, we see that the
effects of climate change will drive existing populations in coastal communities
and rural communities towards cities, causing faster urbanization. As increased
urbanization occurs, we will face increased demand on existing urban systems
and, to a lesser extent, crowding. In Chapter 4, we, again, see that integrated
modeling allow us to endogenize migration dynamics and understand feedbacks
between climate and human mobility.
The primary contribution of this thesis is to show the potential for integrated
models to capture the behavior of complex systems. By endogenizing certain
facets of the system, such as population dynamics, we are able to observe the
systemic issues that affect the observed components. This can be extended
universally to any other issues. We also show that complexity, such as the
collaboration behavior of clinical trials, can be captured with the necessary
data. This complexity can then be related to successful outcomes like drug
approvals.
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5.1 Future of System Dynamics in the
Age of Big Data
Given the incredible explosion of data-availability, system dynamics modelers
are now in a unique position that was previously impossible to explore many
social and health issues with the aid of evidence and data. For much of the
history in system dynamics, modelers had solely to rely on anecdotal and intuitive
logic to formulate the causal relationships between variables because there
did not exist the data to support the intermediate linkages that connect the
input and output variables. With advancements in data collection technology,
researchers are now able to incorporate empirical trends into the model-building
exercise.
The models presented in this thesis demonstrate the potential for integrating
a multi-component model with data from different sources. System dynamics
is a useful medium to tie disparate sources of data together to discover causal
relationships between factors that are usually measured independently. The
aid of machine learning also helps us identify the prominent factors that drive
the system. However, we must supplement these analyses with integrated
system dynamics models to truly understand the underlying causal dynamics.
The conclusions in Chapter 2 demonstrate the need for interdisciplinary
collaboration and diversity of ideas is paramount to accomplishing successful
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research in medicine. This idea can be extended to systems research in public
health and sustainability. For centuries, science has been exclusively conducted
at academic institutions by siloed disciplines that safeguard their research by
constraining the flow of knowledge. However, as we traverse into this brave
new world, where data, information, and knowledge are freely available – we
must learn how to maximize the utility of this unbounded, limitless resource.
System thinking and modeling provides a medium for converting data into
information which is then synthesized into knowledge.
5.2 Summary of Future Work
Since most of our research is an ongoing collaborative process, we will outline
the next steps for each project. The progress and results presented in this
thesis encompass the interdisciplinary work with other researchers.
5.2.1 Clinical Trials and the System Methodology
In Chapter 2, the network analysis was the synthesis of a culmination of
work with the MIT Collaborative Initiatives using the system methodology.
Prof. Sauleh Siddiqui and Prof. Takeru Igusa are promoting many of the ideals
of the MIT Collaborative Initiatives by engaging young and mid-career academic
leaders throughout Johns Hopkins in using systems approaches for grand challenge
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problems. Some of these projects and their leaders, which have all taken
on a broader multidisciplinary systems approach during the past 18 months,
include work on: Native American youth (Allison Barlow, Teresa Brockie),
safe and equitable testing and deployment of autonomous vehicles (Johnathon
Ehsani), suicide in the U.S. (Emily Haroz, Elizabeth Stuart), violence against
children in low- and middle-income countries (Paul Bolton), disparities in the
U.S. health system (John Jackson), and promoting mental and physical activities
to enhance healthy aging (Atif Adam, Michelle Carlson).
5.2.2 Multi-component World Population and Sustainability
Model
In Chapter 3, we propose an integrative method for modeling population
dynamics. In order to aid the transition of developing countries that are undergoing
economic change, the Bill and Melinda Gates Institute for Population and
Reproductive Health will continue to employ models in exploring large-scale
population dynamics in the context of climate change and economic inequity.
5.2.3 US Migration Model
In Chapter 4, we develop a conceptual model with feedback loops. Along
with collaborators at the Bloomberg American Health Initiatives, we will continue
117
CHAPTER 5. CONCLUSION AND OUTLOOK




Coupling Existing Models via
Intermediate Temperature Model
to Study Repeated Hazards
In this appendix, we will introduce a framework for an integrated model and
develop an intermediate model that couples two models of different domains
and scales in order to investigate systemic effects of repeated heatwaves on an
urban environment. The intermediate model is a distributed-lag regression
model that connects a climate model with an agent-based model (ABM) of
city residents. Based on the outcome of the model, we can propose a set of
interventions to aid in disaster preparedness and infrastructure resilience.
Specifically, we want to understand what type of market or policy interventions
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will help reduce the risk of excess mortality rates associated with heatwave
events. This could model could answer questions such as, “How would subsidizing
window-unit air conditioners impact reduce excess mortality?”
The research in this thesis stems from a necessity to integrate an agent-
based social network model and an atmospheric climate model that predicts
temperature. We examined the mid-Atlantic region of the United States. For
the past decades, there has been a focus on developing models that endogenize
physical and social processes related to climate and environmental change
[102]. In order to harness the modeling progress of traditional fields such
as meteorology and sociology, one must be able to couple two separate and
disparate models using an interfacing model that that is logically and causally
consistent with the application domain. In our case, we will focus on this
appendix is to conduct a time series analysis between indoor and outdoor temperatures
since this links the heat effects on human health. To aid with this analysis, we
utilized a distributed lagged regression model that predicts indoor temperature
based on outdoor temperatures.
A.1 Background
Integrated models of resiliency due to hazardous events have been widely
discussed [103]. Other studies have investigated the community resilience
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from an integrated systems perspective [104].
As climate change increases the frequency and intensity of heatwaves [105,
106], cities will inevitably need to take measures to defend against rising mortalities
associated with heatwave events. The occurrence of heatwaves varies geographically
but will affect certain regions that were already prone to heatwaves, such
as the mid-Atlantic region. Heatwaves are generally defined as a period of
relatively extreme, hot temperatures. Relative humidity also plays a large
factor in the health risks of heatwaves. High temperatures are associated with
People spend the majority of their time indoors. Indoor temperatures also vary
depending on building type, area, and behavior of residents [107].
This research was conducted using an interdisciplinary approach to develop
a novel integrated model that includes utilizing an agent-based model to simulate
the learning behavior of residents and their willingness to seek air-conditioned
refuge based on their social network. The data used in this study is based in
Baltimore, Maryland, USA and their respective social connections (e.g. family,
friends). Similar studies have been done in other cities [108], but none has
been done for Baltimore. Additionally, this study will also integrate a climate
model that predicts the outdoor temperature which will serve as an input to
our indoor-outdoor temperature model.
The contribution of our indoor-outdoor temperature model in this thesis is
that it serves as an intermediate model to interface between the ABM and
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Figure A.1: Conceptual framework of the integrated heatwave model. The
integrated model that is shown here requires an intermediate indoor-outdoor
temperature model that bridges the climate-model and ABM (submodel is
highlighted in red). The climate model feeds into the agent based via our
intermediate model (one-way interaction).
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climate model.
The final objectives of the project are to understand
1. the complex interplays between preparedness and resilience of a community
while minimizing the near misses and false alarms,
2. influences of resource constraints and market failures on mitigation decision-
making,
3. interactions between infrastructure and building hardening, land-use change,
and regional resilience,
4. regional climate adaptation decision on regional resilience, and finally,
5. integration of a multidisciplinary approach to regional resilience.
This appendix will focus on objective five. This appendix proposes to couple
two multiscale, dynamic models using a statistical time-series model.
A.2 Data
The indoor temperature profiles were based on the data from [109] which
were collected from homes in Baltimore that have no air conditioning. We
analyzed one representative home with no air conditioning with hourly measurements
for 151 hours (i.e. = N = 151).
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Series Mean Median Minimum Maximum
Indoor Temperature 34.27 34.16 32.76 35.90
Outdoor Temperature 26.92 26.81 22.18 33.86
Table A.1: Summary statistics of indoor and outdoor temperatures in Celsius.
The demeaned series (i.e., Xt − X where X is the mean of the time series)



















































































































































































Figure A.2: Demeaned temperature profiles
From Figure A.2, we notice that there is a strong cyclical period of 24 hours
with outdoor temperature, which reflects the diurnal cycle. The series is also
not quite stationary since we see the outdoor increase up to hour 100 and
decrease afterward while the indoor temperature series continue increasing
throughout the time domain. This cycle can be broken down into daily profiles
(shown in Figure A.3). Here we can see a clearer trend for the cyclical behavior.
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Figure A.3: Daily temperature profiles
From the time series data we were able to observe a lagged correlation
within the data. We were able to calculate the cross-correlation between indoor
temperature and the lagged outdoor temperature time series using the well
known Pearson correlation function,
corr (Xt−k, Yt) =
∑n
i=1(Xi(t−k) −X)(Yit − Y )√∑n
i=1(Xi(t−k) −X)2
∑n
i=1(Yit − Y )2
. (A.1)
Figure A.4 shows the cross-correlation function for different time lags k.
Figure A.5 explicitly shows the scatterplot the indoor and outdoor time series
with respect to different lag sizes. As we can see from both figures, the peak
correlations are at a lag of six hours. In other words, the indoor temperature at
time t has the highest correlation value with the earlier outdoor temperature
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at t− k.
This is consistent with the Diurnal temperature variation between indoor
and outdoor temperatures. As a result, we would need to select a time-series
model with delayed covariates (outdoor temperature) to determine time-specific
indoor temperatures.

















Figure A.4: Cross-correlation plot of indoor and outdoor temperatures. The
lag (k) represents the correlation between an earlier outdoor temperature X at
t − k and indoor temperature Y at t. We see that the highest cross-correlation
between lagged indoor and outdoor temperature is six hours.
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Figure A.5: Scatterplot of Indoor and Outdoor Temperature.
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A.3 Developing the Indoor-Outdoor Temperature
Model
We were able to develop a four demeaned, distributed lagged regression
models with varying orders of lag. The functional forms shown in equations
(A.2),(A.3),(A.4), and (A.5). Selecting this model was based on an intuitive
understanding of the delay between indoor and outdoor temperature. We used
a linear structure for this model since it would allow for faster parameter
estimation. The model also assumes that there are no other time-dependent
factors that affect the indoor temperature estimate, which for the integrated
model is appropriate since we are assuming the agent’s houses are consistent
in structure, ventilation, and insulation.
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where the indoor temperatures Y , is being predicted by the demeaned outdoor
temperatures Xt−k) lagged by k-hours. The predicted values of these four




























Figure A.6: Predicted Indoor Temperatures
Using these models, we were able to fit a dynamic prediction with the goodness-
of-fit metrics located in table A.2. We can see that Equation (A.2), had the best
fit with the R = 0.561. However, for the sake of integration, it is better to use
a more robust model described Equation (A.2), since we can see that the model
overfits in Figure A.6 due to the multicollinearity between the terms and this
might be an issue for integration. Additional work can be done to validate the





































Table A.2: Distributed Lag Model Results
Dependent variable:
InTemp
(A.2) (A.3) (A.4) (A.5)
Outdoor Temp (No Lag) 0.058∗∗ 0.105∗∗∗ 0.027 0.045∗∗
(0.025) (0.020) (0.017) (0.021)
Outdoor Temp (24hr Lag) 0.062∗∗∗
(0.020)
Outdoor Temp (12hr Lag) 0.118∗∗∗ 0.117∗∗∗
(0.020) (0.020)
Outdoor Temp (6hr Lag) 0.118∗∗∗ 0.125∗∗∗ 0.147∗∗∗
(0.015) (0.016) (0.017)
Constant 34.096∗∗∗ 34.060∗∗∗ 34.166∗∗∗ 34.242∗∗∗
(0.051) (0.051) (0.054) (0.067)
Observations 127 127 127 127
R2 0.561 0.528 0.401 0.034
Adjusted R2 0.547 0.516 0.391 0.026
Residual Std. Error 0.508 (df = 122) 0.525 (df = 123) 0.589 (df = 124) 0.744 (df = 125)
F Statistic 39.049∗∗∗ (df = 4; 122) 45.860∗∗∗ (df = 3; 123) 41.530∗∗∗ (df = 2; 124) 4.425∗∗ (df = 1; 125)
Note: ∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01
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A.4 Conclusion and Future Work
To summarize this appendix, we developed the distributed-lag regression
model in order to interface with the agent-based model and existing climate
model. The intermediate model receives the input from the climate model
(i.e. outdoor temperature) and predicts the indoor temperature that the model
agents experience. We see that it is possible to reproduce the diurnal cycle
using the distributed-lag model. Since most mortality of heat waves occur
indoors, the information will be relevant in predicting the health risks. The
fully integrated model with the climate and agent-based modules is still being
developed.
We outlined an integrated and developed an integrated model for heatwave
resilience. Prof. Seth Guikema at the University of Michigan is currently
leading multi-institutional efforts to extend the work on finishing and improving
the integrated heat wave model with an advanced Agent-Based Model that




B.1 Data and Processing
The analysis was performed on the Aggregate Analysis of ClinicalTrial.gov
(AACT) database from the Clinical Trials Transformation Initiative (CTTI) at
Duke University [110] and the BioMedTracker Pharma Intelligence Database
from Informa LLC. The AACT database was accessed on January 12, 2017 and
the Biomed Tracker database was accessed on January 15, 2017.
We used the intersection of the two databases where data existed for the
variables of interest. Each distinct trial is defined as a unique national clinical
trials (NCT) identifier number. The AACT database provided information on
collaboration based on lead sponsor and collaborators. Hence, we were able
to connect each unique NCT number with a set of organizations that were
132
APPENDIX B. NETWORK APPENDIX
affiliated with that particular trial to construct our collaboration network. The
AACT also provided the official start and end dates of each trial. We selected
the trials that were designated as a “drug” interventions as defined by ClinicalTrial.gov.
Our analysis is refined to 4,494 organizations1 and 18,040 trials.
From the BioMedTracker database, we were able to extract the therapeutic
research area through by disease group designation and FDA approval status
of each trial. In our analysis, we considered 21 different disease groups. The
disease group data was used to calculate our knowledge mix, research diversification,
and collaboration diversity indices which will be further defined in the sections.
The trials that were observed are shown in the Figure B.2.
Additional data collection was conducted using a combination of manual
web searches and text-mining to classify each actor into 6 actor categories:
Academic, Government, Nonprofit, Industry, Hospital System, or Large Pharmaceutical.
Table B.1 shows how we categorized each actor. This was done to aid our
regression analysis since the roles of different types of organization vary within
a collaboration network. For example, academic institutions usually collaborate
differently than a nonprofit organization.
1In our analysis, we consider each unique name to be a distinct actor. Therefore,
subsidiaries that have a different name from the parent company were considered to be
separate organizations.
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B.2 Constructing the Collaboration Network
Using the collaborator section of the AACT database, we structured the data
so each clinical trials, which is defined as a unique NCT number is connected
to a set of collaborators and lead sponsor. From this structured data, we
constructed an undirected 2-mode affiliation network that connected actors
(i.e. lead sponsors and collaborators) to a corresponding event (i.e. clinical
trial) based on involvement. The 2-mode network is then utilized to construct
a 1-mode network using bipartite projection to create an undirected, 1-mode
collaboration network. Figure B.1 shows the relationship between a 2-mode
and 1-mode network. The one-mode network is represented as a set of actors
that are actively conducting clinical trials at that particular time. The set of
links exist between pairs of actor that collaborate on the same clinical trials.
All our analysis was performed on the 1-mode network.
We built a distinct network for each month which essentially is a “snapshot”
of all active clinical trials and their associated collaborations. A clinical trial
is considered active in a specific time period if the time period is after the
start date and before the end date as listed in the AACT database. We utilized
the Biomed Tracker database to determine whether a trial was suspended
(failed) or is associated with a treatment that was by the U.S. Food and Drug
Administration (success). The node that represents an actor is removed in the
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time-specific network if it is not involved in any active clinical trials. Hence,
the number of nodes differ between each time period.
Org A Org B Org C Org D
Trial 1 Trial 2 Org A
Org B Org C
Org D
Figure B.1: Bipartite projection of 2-mode affiliation network to a weighted
1-mode collaboration network.
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B.3 Definitions of Actor Metrics and Characteristics
The regression variables are divided into 5 categories: (1) organization
type, (2) expertise, (3) structural measures, (4) collaboration measures, and
(5) organizational measures. The measured variables that were used in the
regression analysis are summarized in Table B.4 in Section B.5.
B.3.1 Organizational Types
In the clinical trials environment, we defined six organization types: Academic,
Government, Nonprofit, Industry, Hospital System, or Large Pharmaceutical.
The organization types of each actor are defined in Table B.1. The organization
type designation for each actor is consistent for all time periods. For each
of the 4,494, we were able to classify the actors by using publicly available
information on the Web. Additionally, we were able to categorize many of the
actors based on their registered names in the AACT database. For example,
if an organization has “LLC,” “Corp.,” or “Inc.” in their name, we can assume
that they belong to industry. Organizations that have “college” or “university”
would be classified as academic institutions.
Furthermore, we differentiated between large pharmaceutical companies
and industry actors based on their revenue, R & D spending, and profit rankings.
The listings for large pharmaceutical companies are listed in Table B.2
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Table B.1: Classifications of Organization Types
Category Description Count
Academic university institutions, academic health
centers, and learning hospitals
639
Government national institutes, ministries, and veteran
hospitals
123
Nonprofit patient advocacy, trusts, initiatives,
collaborative Groups
398
Industry pharmaceutical/biotechnology firms (that
are not considered large pharmaceutical
companies), corporations, multinationals,
holdings, and private clinics
2989




top 25 companies with highest market
capitalization, top 15 revenue, top 15 R&D



























Table B.2: Actors that are considered Large Pharmaceutical Companies
Stryker Orthopaedics AstraZeneca
Johnson & Johnson Eli Lilly and Company
Amgen Research Munich GmbH Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Alexion Pharma GmbH Sanofi
Abbott Medical Optics Wyeth is now a wholly owned subsidiary of Pfizer
Teva Neuroscience, Inc. Hoffmann-La Roche
Johnson & Johnson Medical, China Biogen
Astellas Pharma Europe B.V. Bristol-Myers Squibb
Abbott Products Amgen
Shire Regenerative Medicine, Inc. Pfizer
Merck Serono Co., Ltd., Japan Novartis Pharmaceuticals
Sanofi-Synthelabo GlaxoSmithKline
Teva Women’s Health Celgene Corporation
Merck Serono S.A., Geneva Astellas Pharma Inc
Johnson & Johnson Pte Ltd Astellas Pharma US, Inc.
Teva Pharmaceuticals USA Bayer
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan Genzyme, a Sanofi Company
Stryker Biotech Abbott
Stryker Instruments Gilead Sciences
Daiichi Sankyo UK Ltd. Shire
Sanofi Pasteur MSD Novartis
Stryker Nordic Roche Pharma AG
Durata Therapeutics Inc., an affiliate of Allergan plc Novo Nordisk A/S
Abbott Diabetes Care Alexion Pharmaceuticals
Roche-Genentech Merck KGaA
TEVA Daiichi Sankyo Co., Ltd.
Teva Pharma Takeda
Abbott Japan Co.,Ltd Daiichi Sankyo Inc.
Astellas Pharma Global Development, Inc. Allergan
Allergan Medical Abbott Vascular
Abbott Diagnostics Division Teva Pharmaceutical Industries
Astellas Pharma Europe Ltd. Vertex Pharmaceuticals Incorporated
Celgene Orthovita d/b/a Stryker
Stryker MAKO Surgical Corp AbbVie prior sponsor, Abbott
Merck Serono S.A., Switzerland Stryker Neurovascular
Astellas Pharma China, Inc. Regeneron Pharmaceuticals
Stryker MAKO Corp Boehringer Ingelheim
Genentech/Roche Teva Branded Pharmaceutical Products, R&D Inc.
Johnson & Johnson Medical Companies Sanofi Pasteur, a Sanofi Company
Bristol Meyers Squibb BMS AbbVie
Teva Pharmaceutical Industries, Ltd. Shire Human Genetic Therapies, Inc.
Janssen/GlaxoSmithKline Janssen, LP
Janssen, GlaxoSmithKline GSK King Pharmaceuticals is now a wholly owned subsidiary of Pfizer
Astellas Pharma Korea, Inc. Gamida Cell -Teva Joint Venture Ltd.
Stryker South Pacific Novartis Vaccines
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B.3.2 Expertise
Each trial in the BioMedTracker database is associated with therapeutic
area based on the main treatment objectives. In our sample from the BioMedTracker
database, there are 21 different therapeutic areas. Figure B.2 shows the distribution






















0 2000 4000 6000 8000
Trials
Figure B.2: The distribution of trials in our analysis is shown by therapeutic
disease groups from Jan 2006 - Jan 2016
We assumed that the experience and data gained from a clinical trial contributes
to the knowledge regarding the therapeutic area. For each actor, we were able
to designate them as an expert in a therapeutic area by simply looking at the
most trials that the actor was involved with.
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B.3.3 Structural Measures
Betweenness Centrality






s.t. j ̸= k
where σij represents the shortest path between nodes i and j and σjk(i) represents
the total number of shortest paths that goes through node i. This metric is
useful for measuring the extent to which a node acts as a bridge between two
communities.
The actors that have a high betweenness centrality in the clinical trials
collaboration network represents are in positions that would enable them to
be a conduit for knowledge flow. Furthermore, these organizations that are in
central positions with a high betweenness centrality are also able to tap into
the different knowledge bases of a variety of actors. Many large pharmaceutical
organizations have a high betweenness centrality. Actors that have low betweenness
centrality are typically on the peripheries of a network, such as biotechnology
and life science startups.
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Figure B.3: Rank-size plot for betweenness centrality for Januarys of 2007,
2011, and 2015.
Clustering Coefficient
The local clustering coefficient CCit measures the extent to which a node’s
neighbors all belong to a clique. Formally, the local clustering coefficient for an




where Lit represents the number of links between the neighbors of actor i at
time t, and δit represents the number of degrees of actor i at time t.
The local clustering coefficient has been shown to be a good indicator of
local cohesiveness [36]. The local clustering coefficient also provides us with
a measure of how close the local neighborhood of a network is a clique. In
the context of collaboration trials, actors that have high measures of local
clustering tend speed of knowledge transfer [29]. However, local clustering can
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also result in knowledge redundancy in which organizations are essentially
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Figure B.4: Rank-size plot for local clustering coefficient for Januarys of 2007,
2011, and 2015. Nodes with less than 2 neighbors are removed.
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Degree Centrality
Per conventional definition of degree centrality, this is simply the number
of links that are adjacent to the observed node, which we will define as δit. Also
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Figure B.5: Rank-size plot for degree centrality for Januarys of 2007, 2011, and
2015. Nodes with less than 2 neighbors are removed.
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B.3.4 Organizational Measures
Knowledge Mix
Similar to the knowledge space index was developed by Tomasello et al. [43]
to show the distribution of research in different industrial patent areas, our
knowledge mix index shows the distribution of an actor’s research portfolio in
each disease group research area. They considered knowledge to be demonstrated
when a company files a patent in a certain industrial area (e.g. aerospace,
pharmaceutical, manufacturing), while we considered knowledge mix to be
trials that were conducted in each disease group area. We utilize the knowledge
mix index to determine the amount of experience gained when an organization
conducts research in a particular disease domain. As shown in the main article,
the knowledge mix for organization i is defined as a vector xi with the element




∀i ∈ F , ∀d ∈ D (B.1)
The set of firms and therapeutic diseases area are represented respectively
as F and D . If organization i does not have any approvals, then the knowledge
mix is a null vector xi = 0. We define experience (i.e. knowledge) as nid which
represents the number of clinical trials in the therapeutic area d that actor i
has been involved as a sponsor or partner.
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Since the knowledge mix is not a scaler, it was not used directly in our
regression analysis. However, the knowledge mix is used to calculate research
diversification, mean neighbor research diversification, knowledge distance,
and collaboration diversity.
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Research Diversification
On a firm level, an organization may decide to adopt two approaches: broadly
diversify in different therapeutic disease areas (i.e. “jack-of-all-trades”) or specialize
in one therapeutic disease area (i.e. “master-of-one”). The decision to diversify
is usually driven by the size of the organizations which determines the economies
of scope [45]. Larger companies tend to diversify more than smaller companies.
Furthermore, the firm must decide whether to collaborate with a jack-of-all-
trades or a master-of-one that has a deep understanding in one field.
We quantified research diversification using an entropic measure that measures










where xid is the element of the knowledge mix vector that represents the percentage
of clinical trials experience in disease d. This measure gives us an impression of
the level of interdisciplinary in an organization’s research portfolio. We assume
that a company that has completed 0 trials will have an entropy of 0.
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Tomasello et al. [43] defined the knowledge distance as the Euclidean distance
between organizations i and j at time t. In other economic literature, this is
known as the technological distance [44]. This is formally defined as
KDijt = ∥xj − xj∥ =
√∑
d∈D
(xid − xjd). (B.3)
where xid represents an element of the knowledge mix vector xj that was defined
in B.3.4.
This link-specific metric was meant to compare the differences between two
firms’ patent portfolios. However, we have adopted this metric to measure
the differences between pairs of the organization’s research portfolio (i.e. the
distribution of trial experience in each therapeutic area). The knowledge distance
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is at a maximum (KD =
√
2) when actors are concentrated in two different
therapeutic areas. When two firms are concentrated in the same therapeutic
area, the knowledge distance equals to 0 because they are identical in expertise.
One of the properties of the Euclidean-based knowledge distance in (B.3) is
that the measure takes into account research diversification of an actor. Let’s
say Actor 1’s research portfolio is solely concentrated in Neurology, Actor 2 is
solely concentrated in Urology, and Actor 3 is divided between Oncology and
Urology. In this situation, the known distance between Actor 1 and Actor 2 is
larger than Actor 1 and Actor 3 even despite the fact that both Actor 2 and 3 are
in exclusive research fields relative to Actor 1. This is a well-known property
of Euclidean Distances and fits our case since we are implying that actors that
are more interdisciplinary have more capacity to function in other fields than
specialists.
In our analysis, we calculate the mean knowledge distance ⟨KD⟩it for all
incident links to actor i at time t, and used it as a variable in our regression.





s.t. i ̸= j
where δi is the number of degrees for actor i.
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Figure B.7: Rank-size plot for Mean Knowledge Distance for Januarys of 2007,
2011, and 2015.
149
APPENDIX B. NETWORK APPENDIX
Collaboration Diversity
For each actor, the collaboration diversity measures how interdisciplinary
the collaborators are in a given instance. Specifically, we determine how many
experts in each field an actor is collaborating with and how heterogeneous that
distribution is.
By simply observing which element of the knowledge mix vector in Section
B.3.4 that has the largest value, we can determine the therapeutic area that
an actor would be considered an “expert.”2 Based on this method, we were able
to designate each node in our graph with an expertise and calculate the level of
diversity of collaborators for each actor. This measure is similar to the entropic
measure in Equation (B.2).
For each actor i, there exist a set of collaborators (neighbors) Ni with a
corresponding vector of expertise count zi(Ni). The element zid ∈ zi is equal to
number of collaborators that are experts in therapeutic field d. We can formally










For actors that have no collaborators, we assume CD = 0.
2For some of the actors, they have expertise in 2 or more therapeutic areas (e.g.
maxd∈D xid = xi1 = xi2). In these cases, we designate the actors as a separate group from
the rest of the therapeutic designations. Partners with no expertise in any therapeutic areas
are excluded.
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Figure B.8: Rank-size plot for Collaboration Diversity for Januarys of 2007,
2011, and 2015.
Mean Neighbor Research Diversification
From the research diversification that is defined in Equation (B.2), we can
determine mean research diversification of all the neighboring organization of






where δi is the number of degrees for node i.
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Figure B.9: Rank-size plot for Mean Neighbor Research Diversification for
Januarys of 2007, 2011, and 2015.
B.4 Fitting Regression Models
Using the set of 121 temporal collaboration networks that was constructed,
we created a panel dataset composed of the network measures in Section B.3.3.
We plotted the trends for all of the months in Figure 2 in the main article. For
our regression analysis, we discretized the data based on 6-month intervals,
starting in January 2006 and ending in January 2016 (19 time periods).
In order to obtain explanatory relationships of each network measure on
treatment development success, we respectively utilized a negative-binomial
generalized linear model (GLM) and beta regression model to predict two sets
of lagged dependent variables that represent research output and productivity:
cumulative trial successes and trial success rate. Given that cumulative trial
successes are a count variable, we selected the negative binomial regression
was selected to be our model. We selected negative binomial regression for
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the cumulative trial success over Poisson regression due to the over-dispersion
of the response variable. For the trials success rate, the beta regression was
selected to predict a response variable with a continuous unit interval (0,1).
We also considered 3 different lag lengths: 1, 2, and 5 years to analyze
time-scale effects. For each dependent variable, we developed the main model
by heuristically eliminating variables based on the variational inflation factor
(VIF) and P-value of each regression estimation. The main model was fitted
for all 3 lag durations. The GLM and beta regression models are defined
in Equations (B.5) and (B.6) respectively, and referenced in the main article.
We have found that the main model is the most useful since it only includes
variables that have significant explanatory power and reduced multicollinearity.
In addition to the main model, we also developed a base model with only
control variables and a comprehensive model with all variables. The results
for the base model (control variables), main model (selected variables), and
comprehensive model (all variables) are shown in Tables B.5 - B.7 and B.9 -
B.11. We also included
To account for confounding temporal factors (e.g. regulations, policy changes),
we added fixed effects for each time period. We also included fixed effects for
each organizational class (e.g. academic, nonprofit) to capture the differences
in actors’ behaviors.
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The GLM and beta Regression will have the following form
g(yijt) = β0 + β1x1ij(t−k) + β2x2ij(t−k) + . . .+ βMij(t−k) + γt + κj + ϵijt
where g(·) is the link function and γt is the fixed effect of each 6-month time
interval between 2006-2016. There are M covariates (independent variables)
designated as xijk that measures an attribute of actor i of organization type j
at time t. We employed the statistical software R to estimate the coefficients
β using the method of maximum likelihood to regress against the response
variable yijt.
B.4.1 Cumulative Trial Successes Regression
We utilized a negative binomial regression class of GLMs to estimate the
linear relationship of cumulative trial successes CTSijt for all actors i of organization
type j and time t. Our main model is defined as
log(CTSit) = β0 + β1PrevSucci(t−k) + β2Trialsi(t−k) + β3CDi(t−k) + β4⟨KD⟩i(t−k)
+ β5CCi(t−k) + γt + κi + ϵit (B.5)
The variables that were selected for this model include attributes that depict
network, collaboration and organization characteristics that gave us the highest
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cross-validation predictive accuracy using the method of random holdouts. These
covariates include previous success dummy PrevSucci(t−k), cumulative trials
conducted Trialsi(t−k), collaboration diversity CDi(t−k), mean knowledge distance
⟨KD⟩i(t−k), and local clustering coefficient CCi(t−k). We standardized cumulative
trials conducted, collaboration diversity, mean knowledge distance, and local
clustering coefficients in the main model.
Since the dependent variable is lagged, all the independent variables are
taken from an earlier period in our panel dataset with lag differences k =
1, 2, and 5 years. The dummy variables γt and κi are the fixed effects of
time and organizational class per Table B.1. All non-dummy variables were
standardized to control for varying magnitudes. For more information on these
variables, refer to Section B.3. The coefficients for (B.5) are listed as Models
A1-2, A2-2, and A3-2 in Tables B.5 - B.7.
It is possible that there exists a reverse causality in which the network
structure is the result of the organizational success of the company which
makes the network metrics endogenous. For instance, organizations may want
to work with a more successful company (i.e., preferential attachment), resulting
in more trials. We attempted to control the endogenous effects by including
past success as a dummy variable PrevSucci(t−k) in order to account for confounding
factors between network structure and cumulative success in trials. In our
model, PrevSucct−k = 1 when a company has participated in at least one successful
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clinical trial at or before time t− k, otherwise PrevSucc = 0.
To illustrate the robustness of our model to explain cumulative trial successes,
two other set of regression models were developed in addition to (B.5) to explain
the relative effects of all the variables. The base models A1-1, A2-1, and A3-1
only include the control variables while the comprehensive models A1-3, A2-3,
and A3-3 include all the variables. Along with the standardized variables in
the main model, betweenness centrality and collaboration diversity were also
standardized in the comprehensive model. The 3 sets of models for each time
lag (1 year, 2 years, and 5 years) resulted in a total of 9 models with results
in Tables B.5 - B.7. We also included a comparison of these models using
a likelihood ratio test in Table B.8 since the three models are nested within
each other. The results show that most of our selected variable’s p-values in
the main model for all three lag sizes are significant to at least P < .01 with
most of them being significant to P < .001. All VIFs are less than 3 for all
models. Previous success has the largest positive effect and that effect size was
inversely related to lag sizes. Mean knowledge distance has a negative effect
for 1 and 2 years lags, while local clustering coefficient had a negative effect for
all lag sizes.
There is evidence of overdispersion in our data since overdispersion parameter
θ is greater than 2.2 for 1 and 2-year lags. There is less overdispersion for
the 5 year lag with θ > 1.1. We also assume linearity in our model since we
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do not observe any distinct higher-order polynomial relationship between the
response and explanatory variables.
B.4.2 Trial Success Rate Regression
The trial success rate was analyzed using beta regression for lags of 1, 2,
and 5 years. Trials success rate SRit is defined as the cumulative number of
successful clinical trials divided by the total number of trials conducted up to




Since the Trials Success Rate in our panel dataset includes 1 and 0 values
which are excluded in a beta regression, we transformed the SR into the dependent




The resulting model is
logit(SRit) = β0 + β1PrevExpi(t−k) + β2⟨KD⟩i(t−k) + β3CCi(t−k) + β4RDi(t−k)
+ β5⟨RD⟩i(t−k) + γt + κi + ϵit (B.6)
For the beta regression model, mean knowledge distance ⟨KD⟩i(t−k), clustering
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coefficient CCi(t−k), research diversificationRDi(t−k), and mean neighbor’s research
diversification ⟨RD⟩i(t−k) were standardized. The dummy variable PrevExpi(t−k)
is meant to capture whether the organization has previous experience in clinical
trials. Specifically, PrevExpi(t−k) is equal to 1 if the actor has conducted more
than 6 trials3 before time t−k. For the beta regression models, we also controlled
for time using fixed effect dummy variables γt. The fixed effects for each organizational
class (defined in Table B.1) are captured in κi. For our OLS models, we assumed
the link function is an identity function per convention. The main models with
the selected variables defined in Equation (B.6) are listed as Model B1-2, B2-2,
and B3-2 in Tables B.9 - B.11.
As we did for the analysis of cumulative trial successes, we developed 2
sets of beta regression models using control variables and all variables to show
robustness. The base beta regression models with only the control variables
are listed as base models B1-1, B2-1, and B3-1. The comprehensive models B1-
3, B2-3, and B3-3 show the beta regression with all the interesting variables.
The results are shown in Tables B.9 - B.11. In our base model, most variables
with significance of least P < .001. The previous experience dummy variable
was not significant for a 5-year lag. The local clustering coefficient was the only
variable with a negative effect for all lag sizes.
The dependent variable in our data follows a beta distribution. Our data
3we used 6 because it is the average number of trials
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is relatively noisy therefore we are assuming that the response variable and
explanatory variables have a linear relationship which is consistent with the

























B.5 Supplementary Tables and Figures
Table B.3: Summary Statistics of Variables (Unstandardized)
Statistic N Mean St. Dev. Min Max
Cumulative Trial Success 9,775 2.684 9.610 0 187
Trial Success Rate 9,775 0.283 0.369 0.000 1.000
Cumulative Trials Conducted 9,775 5.451 19.044 0 398
Mean Knowledge Distance 9,775 0.768 0.272 0.000 1.414
Local Clustering Coefficient 9,775 0.441 0.294 0.000 1.000
Vertex Degree 9,775 27.673 39.929 2 258
Research Diversification 9,775 0.334 0.536 0.000 2.262
Mean Neighbor Research Diversification 9,775 0.706 0.438 0.000 2.262
Betweenness Centrality 9,775 4,815.421 9,910.420 0.000 110,661.500

























Table B.4: Summary of Variables




Number of trials (phases) conducted up to time t
that led to an FDA approved treatment
trials BiomedTracker
Trial Success Rate Rate of trials (phases) that led to an FDA approved





The mean of all incident edge’s (i.e. collaborations)




Measures the degree to which a node’s neighbors
are a clique
n/a AACT














Network measure determining the extent that a




The number of trials that an actor has conducted up




The diversity of collaborators with respect to their
specialization
n/a AACT/BiomedTracker
Previous Success Actor has participated in at least one trial that led
to an FDA approved treatment
0/1 BiomedTracker

























Table B.5: Negative Binomial Regression on Cumulative Trials Success (1-year lag)
Cumulative Trials Success
(Model A1-1) (Model A1-2) (Model A1-3)
Control Variables Selected Variables All Variables
Previous Success 2.665∗∗∗ 2.709∗∗∗ 2.572∗∗∗
(0.036) (0.036) (0.038)
Cumulative Trials Conducted 0.479∗∗∗ 0.331∗∗∗ 0.290∗∗∗
(0.008) (0.007) (0.009)
Collaboration Diversity 0.240∗∗∗ 0.182∗∗∗
(0.015) (0.017)
Mean Knowledge Distance −0.330∗∗∗ −0.248∗∗∗
(0.016) (0.018)
Local Clustering Coef. −0.075∗∗∗ −0.064∗∗∗
(0.014) (0.014)






Constant −2.317∗∗∗ −2.623∗∗∗ −2.460∗∗∗
(0.135) (0.130) (0.130)
Observations 9,775 9,775 9,775
Log Likelihood −11,613.780 −11,256.750 −11,212.030
θ 2.651∗∗∗ (0.090) 3.419∗∗∗ (0.131) 3.635∗∗∗ (0.143)
Akaike Inf. Crit. 23,279.560 22,571.500 22,488.050
∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01

























Table B.6: Negative Binomial Regression on Cumulative Trials Success (2-year lag)
Cumulative Trials Success
(Model A2-1) (Model A2-2) (Model A2-3)
Control Variables Selected Variables All Variables
Previous Success 2.113∗∗∗ 2.177∗∗∗ 2.029∗∗∗
(0.030) (0.031) (0.035)
Cumulative Trials Conducted 0.438∗∗∗ 0.301∗∗∗ 0.251∗∗∗
(0.009) (0.008) (0.010)
Collaboration Diversity 0.270∗∗∗ 0.213∗∗∗
(0.015) (0.017)
Mean Knowledge Distance −0.263∗∗∗ −0.194∗∗∗
(0.017) (0.018)
Local Clustering Coef. −0.084∗∗∗ −0.074∗∗∗
(0.014) (0.014)






Constant −1.531∗∗∗ −1.877∗∗∗ −1.723∗∗∗
(0.116) (0.111) (0.112)
Observations 9,131 9,131 9,131
Log Likelihood −11,870.990 −11,578.300 −11,536.560
θ 2.230∗∗∗ (0.081) 2.850∗∗∗ (0.116) 2.987∗∗∗ (0.125)
Akaike Inf. Crit. 23,789.990 23,210.600 23,133.110
∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01

























Table B.7: Negative Binomial Regression on Cumulative Trials Success (5-year lag)
Cumulative Trials Success
(Model A3-1) (Model A3-2) (Model A3-3)
Control Variables Selected Variables All Variables
Previous Success 1.390∗∗∗ 1.285∗∗∗ 1.127∗∗∗
(0.044) (0.046) (0.051)
Cumulative Trials Conducted 0.321∗∗∗ 0.236∗∗∗ 0.092∗∗∗
(0.015) (0.015) (0.021)
Collaboration Diversity 0.269∗∗∗ 0.186∗∗∗
(0.021) (0.022)
Mean Knowledge Distance 0.045∗∗ 0.092∗∗∗
(0.020) (0.021)
Local Clustering Coef. −0.154∗∗∗ −0.128∗∗∗
(0.019) (0.019)






Constant −0.692∗∗∗ −0.797∗∗∗ −0.743∗∗∗
(0.093) (0.092) (0.092)
Observations 6,094 6,094 6,094
Log Likelihood −9,527.913 −9,378.134 −9,335.782
θ 1.115∗∗∗ (0.043) 1.289∗∗∗ (0.053) 1.338∗∗∗ (0.056)
Akaike Inf. Crit. 19,091.830 18,798.270 18,719.560
∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01
Note: The fixed effects of time and organizational class are not shown. All underlined variables are standardized.
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Table B.8: Likelihood Ratio Test for Cumulative Trials Success Regression
Models
Lag Model theta Resid. df 2 x log-lik. Test df LR stat. Pr.Chi.
1 year A1-1 2.65 9749 -23225.56
1 year A1-2 3.42 9746 -22511.50 A1-1 vs A1-2 3 714.06 0.00
1 year A1-3 3.63 9743 -22422.05 A1-2 vs A1-3 3 89.45 0.00
2 year A2-1 2.23 9107 -23739.99
2 year A2-2 2.85 9104 -23154.60 A2-1 vs A2-2 3 585.39 0.00
2 year A2-3 2.99 9101 -23071.11 A2-2 vs A2-3 3 83.49 0.00
5 year A3-1 1.12 6076 -19053.83
5 year A3-2 1.29 6073 -18754.27 A3-1 vs A3-2 3 299.56 0.00

























Table B.9: Beta Regression on Trials Success Rate (1-year lag)
Trials Success Rate
(Model B1-1) (Model B1-2) (Model B1-3)
Control Variables Selected Variables All Variables
Previous Experience 0.404∗∗∗ 0.236∗∗∗ 0.238∗∗∗
(0.043) (0.052) (0.053)
Mean Knowledge Distance 0.025∗ 0.028∗∗
(0.014) (0.014)
Local Clustering Coef. −0.037∗∗∗ −0.041∗∗∗
(0.014) (0.015)
Research Diversification 0.092∗∗∗ 0.097∗∗∗
(0.019) (0.020)






Constant −0.533∗∗∗ −0.434∗∗∗ −0.422∗∗∗
(0.146) (0.147) (0.147)
Observations 9,775 9,775 9,775
R2 0.037 0.052 0.053
Log Likelihood 36,126.930 36,171.430 36,172.170
∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01

























Table B.10: Beta Regression on Trials Success Rate (2-year lag)
Trials Success Rate
(Model B2-1) (Model B2-2) (Model B2-3)
Control Variables Selected Variables All Variables
Previous Experience 0.412∗∗∗ 0.196∗∗∗ 0.196∗∗∗
(0.049) (0.061) (0.061)
Mean Knowledge Distance 0.034∗∗ 0.038∗∗∗
(0.014) (0.014)
Local Clustering Coef. −0.041∗∗∗ −0.044∗∗∗
(0.015) (0.015)
Research Diversification 0.103∗∗∗ 0.109∗∗∗
(0.020) (0.021)






Constant −0.787∗∗∗ −0.671∗∗∗ −0.658∗∗∗
(0.116) (0.117) (0.118)
Observations 9,131 9,131 9,131
R2 0.037 0.057 0.057
Log Likelihood 32,728.370 32,782.770 32,784.110
∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01

























Table B.11: Beta Regression on Trials Success Rate (5-year lag)
Trials Success Rate
(Model B3-1) (Model B3-2) (Model B3-3)
Control Variables Selected Variables All Variables
Previous Experience 0.362∗∗∗ 0.077 0.055
(0.083) (0.105) (0.107)
Mean Knowledge Distance 0.031∗ 0.038∗∗
(0.018) (0.018)
Local Clustering Coef. −0.040∗∗ −0.041∗∗
(0.018) (0.018)
Research Diversification 0.102∗∗∗ 0.100∗∗∗
(0.026) (0.027)






Constant −0.822∗∗∗ −0.750∗∗∗ −0.740∗∗∗
(0.087) (0.088) (0.089)
Observations 6,094 6,094 6,094
R2 0.033 0.050 0.051
Log Likelihood 18,953.220 18,986.650 18,988.750
∗p<0.1; ∗∗p<0.05; ∗∗∗p<0.01
Note: The fixed effects of time and organizational class are not shown. All underlined variables are standardized.
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Figure B.10: Correlation matrix for the network, organizational, and
collaboration measures over the 2006-2016 time frame at 6-month intervals
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Figure B.11: The scatterplot comparing collaboration diversity and local
clustering coefficient for each actor. Large pharamceutical companies and
other actors are distinguished by shapes. The color gradient is scaled based
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Figure B.12: Global characteristics of the network from 2006 to 2016. The black





























































































































































Equations for a multi-component
global population model






Age Group :A =
{
Age Group 1, . . . ,Age Group 4
}





APPENDIX C. EQUATIONS FOR A MULTI-COMPONENT GLOBAL
POPULATION MODEL
Equations
Age Group 1 (0-14 years) :
dP1jr(t)
dt







DR1jkr(t) · P1jkr(t) (C.1)










DR2jkr(t) · P2jkr(t) (C.2)










DR3jkr(t) · P3jkr(t) (C.3)







DR4jkr(t) · P4jkr(t) (C.4)
Total Fertility Rate : TFRr(t) = CMr(t) · CCr(t) · TNM (C.5)
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General Fertility Rate :GFRr(t) = β1 · TFRr(t) (C.8)




















Death Rate :DRijkr(t) =MDRijkr +DFijkr(t) +DHijkr(t)
(C.12)




































































Table C.1: Variables for Population Submodel
Variables Description Type
Bjr Birth count in for sex j and socioeconomic group k in region r Endogenous
CCk Bongaart’s fertility index for contraception for socioeconomic group k in region r Endogenous
CMr Bongaart’s fertility index for marriage for socioeconomic group k in region r Endogenous
DFijkr Food shortage impact on deaths for age group i, sex j, socioeconomic group k in region r Endogenous
DHijkr Health service shortage impact on deaths for age group i, sex j, and socioeconomic group k in region r Endogenous
DRijkr Death rate in age group i, sex j, and socioeconomic group k in region r Endogenous
EFr Female access to education in region r Endogenous
N̂C ijkr Nutrition consumption per capita for age group i, sex j, and socioeconomic group k in region r Endogenous
N̂R Nutrition requirement per capita Endogenous
GFRr General fertility rate in region r Endogenous
HAkr Socioeconomic group k’s access to health care in region r Endogenous
HFr Females’ access to health care in region r Endogenous
MDRijkr Minimum death rate for age group i, sex j, socioeconomic group k in region r Constant
MR(i−1)ij Maturation rate from age i− 1 to i Constant
Pijkr Population count in age group i, sex j, and socioeconomic group k in region r Endogenous
sM Male sex ratio Constant
TF Total fecundity Constant
TFRr Total fertility rate in region r Endogenous
TNM Total natural marital fertility Constant
TPr Total population Size in region r Endogenous
αCr Regression intercept for CCr Constant
αMr Regression intercept for CMr Constant
βECr Education services regression coefficient for CCr Constant
βEMr Education services regression coefficient for CMr Constant
βHCr Health services regression coefficient for CCr Constant
ωFijkr Food shortage effect on death rate for age group i, sex j, and socioeconomic group k in region r Constant
ωHijkr Barriers to health services effect on death rate for age group i, sex j, and socioeconomic group k in region r Constant
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C.2 Health and Education Submodel Equations
and Variables
Sets




Age Group : A =
{
Age Group 1, . . . ,Age Group 4
}
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Equations




Change in education services :
dESr(t)
dt
= EGr(t)− EDr(t) (C.16)
Growth in health services :HGr(t) = ΛHr ·∆Yr(t) (C.17)
Growth in education services :EGr(t) = ΛEr ·∆Yr(t) (C.18)
Health service depreciation :HDr(t) = ζHr ·HSr(t) (C.19)
Education service depreciation :EDr(t) = ζCr · ESr(t) (C.20)





































































Table C.2: Variables for Health and Education Submodel
Variables Description Type
EDr Depreciation education services in region r Endogenous
EFkr Female education attainment for socioeconomic group k in region r Endogenous
EGr Growth in education services in region r Endogenous
ESr Education services availability in region r Endogenous
HAkr General healthcare access for socioeconomic group k in region r Endogenous
HDr Depreciation of health services in region r Endogenous
HGr Growth in health services in region r Endogenous
EFkr Female education attainment for socioeconomic group k in region r Endogenous
HFkr Female access to maternal health services for socioeconomic group k in region r Endogenous
HSr Health Services in region r Endogenous
Yr Economic output in region r Endogenous
Ŷkr Economic output per capita of socioeconomic group k in region r Endogenous
ΛEr Education development relative to econonomic output in region r Exogenous
ΛHr Health development relative to econonomic output in region r Exogenous
χEF1kr Fixed effect on female education attainment for socioeconomic group k in region r Exogenous
χHA1kr Fixed effect on healthcare access for socioeconomic group k in region r Exogenous
χHF1kr Fixed effect on female healthcare impact for socioeconomic group k in region r Exogenous
χEF2kr Education services impact on female education attainment for socioeconomic group k in region r Exogenous
χHA2kr Health services impact on healthcare access for socioeconomic group k in region r Exogenous
χHF2kr Health services impact female healthcare impact for socioeconomic group k in region r Exogenous
χHA3kr Income per capita impact on healthcare access for socioeconomic group k in region r Exogenous
ζHr Depreciation rate of health services in region r Exogenous
ζEr Depreciation rate of education services in region r Exogenous
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C.3 Economy Submodel Equations and
Variables
Sets




Age Group : A =
{
Age Group 1, . . . ,Age Group 4
}
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Equations
Accessible Nonrenewable Resource :Nr(t) = ΛNr ·N(t) (C.24)
Accessible Renewable Resource :Rr(t) = ΛRr ·R(t) (C.25)
Economic output :Yr(t) = Ar · Lr(t)η1r ·Kr(t)η2r (C.26)
Change in economic output :∆Yr(t) = Yr(t)− Yr(t− 1) (C.27)




Change in income per capita :∆Ŷr(t) = Ŷr(t)− Ŷr(t− 1) (C.29)
Change in capital :
dKr(t)
dt
= ∆Kr(t) = Ir(t)−KDr(t) (C.30)
Capital investment :Ir(t) = θKr · Yr(t) ·Nr(t) ·Rr(t) (C.31)
Capital depreciation :KDr(t) = ιK ·Kr(t) (C.32)







ERijkr · Pijkr(t) (C.33)
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Table C.3: Variables for Economic Submodel
Variables Description Type
Ar Technology efficiency multiplier in region r Constant
Ir Capital investment flows in region r Endogenous
Kr Capital in region r Endogenous
KDr Capital depreciation in region r Endogenous
Lr Employed labor force in region r Endogenous
N Global nonrenewable resources reserves Endogenous
Nr Nonrenewable resources reserves in region r Endogenous
Pijkr Population of age i, sex j, and socioeconomic group k in region r Endogenous
Qr Inequality in region r Endogenous
ERijkr Employment-to-working population ratio for age i, sex j, and socioeconomic group k in region r Constant
R Global renewable resource reserves Endogenous
Rr Renewable resource reserves in region r Endogenous
TPr Total population in region r Endogenous
Yr Economic output in regionr Endogenous
Ŷr Income per capita in region r Endogenous
∆Ŷr Change in income per capita in region r Endogenous
ιK Capital depreciation rate Constant
ΛNr Fraction of global nonrenewable resource reserves in region r Constant
Λ(Rr) Fraction of global renewable resource reserves in region r Constant
Ψr Inequality parameter in region r Constant
θR Capital investment intensity in region r Constant
η1r Human capital production input elasticity in region r Constant
η2r Capital production input elasticity in region r Constant
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C.4 Global Natural Resources Submodel
Equations and Variables
Sets
Income Regions : R =
{
Low Income Countries,
Middle Income Countries, High Income Countries
}
Equations
Change in renewable resource :
dR(t)
dt
= RP (t)−RC(t) (C.35)
Replenishment of renewable resources :RP = δR ·R(t) (C.36)




Renewable resources consumption :RC(t) =
∑
r∈R
ιRr · Yr(t) (C.38)
Nonrenewable resources consumption :NC(t) =
∑
r∈R
ιNr · Yr(t) (C.39)
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Table C.4: Variables for Global Natural Resources Submodel
Variables Description Type
N Global nonrenewable resource reserves Endogenous
NC Nonrenewable resource consumption Endogenous
R Global renewable resource reserves Endogenous
RC Renewable resource consumption Endogenous
RP Renewable resource replenishment flow Endogenous
Yr Economic output in region r Endogenous
δR Renewable resource replenishment rate Constant
ιNr Nonrenewable resource consumption intensity in region r Constant
ιRr Renewable resource consumption intensity in region r Constant
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C.5 Global Climate Submodel Equations
and Variables
Sets
Income Regions : R =
{
Low Income Countries,
Middle Income Countries, High Income Countries
}
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Equations
Change in temperature :
dT (t)
dt
= λ ·RF (t) (C.40)
Radiative forcing : RF (t) = 5.35 · ln G(t)
G0
+RFEXT (C.41)
Change in CO2 concentration :
dG(t)
dt
= Ĝ(t) · TP (t)−GS (C.42)
CO2 storage GS = Γ ·G(t) (C.43)
CO2 emission : G(t) =
∑
r∈R
Ĝr · TPr (C.44)
CO2 emission per capita : Ĝr = Ŷr(t)ψE (C.45)
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Table C.5: Variables for Climate Submodel
Variables Description Type
G CO2 concentration in the atmosphere Endogenous
Ĝ CO2 emission per capita Endogenous
G0 Reference CO2 concentration in the atmosphere Constant
GS CO2 storage Endogenous
RF Radiative forcing from CO2 Endogenous
RFEXT Radiative forcing from other GHG Constant
T Global temperature Endogenous
TPr Total population in region r Endogenous
Ŷr Income per capita in region r Endogenous
Γ Storage rate of CO2 Constant
λ Climate sensitivity Constant
ψE CO2 emission rate relative to economic income Constant
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C.6 Global Water Resources Submodel
Equations and Variables
Sets
Income Regions :R =
{
Low Income Countries,
Middle Income Countries, High Income Countries
}
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= WP (t)−WC(t)−WL(t) (C.46)
Water replenishment :WP (t) = W (t) ·NWR (C.47)
Water loss due to climate change :WL(t) = CCW(t) ·W (t) (C.48)




Municipal demand for water :WDM(t) =
∑
r∈R
ŴRMr · TPr(t) (C.50)




Global demand for water :WD(t) = WDM(t) +WDA(t) +WDI(t)
(C.52)









APPENDIX C. EQUATIONS FOR A MULTI-COMPONENT GLOBAL
POPULATION MODEL
Table C.6: Variables for Water Submodel
Variables Description Type
CCW Climate change effects on water supply Endogenous
NWR Natural water replenishment rate Constant
Pij Population count in age group i and sex j Endogenous
T Global temperature Endogenous
T0 Initial global temperature Constant
W Freshwater supply (Total renewable actual water sources) Endogenous
WC Global water consumption rate Endogenous
WD Global water demand Endogenous
WDA Agricultural demand for water Endogenous
ŴDMr Municipal water demand per capita in region r Endogenous
WDM Municipal demand for water Endogenous
WDI Industrial demand for water Endogenous
WL Water loss due to climate change Endogenous
WP Water replenishment Endogenous
Yr Economic Output in region r Endogenous
δW Water loss sensitivity to climate change Constant
ζI Consumption of water per unit of economic output Y Constant
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Age Group :A =
{
Age Group 1, . . . ,Age Group 4
}




Income Regions :R =
{
Low Income Countries,
Middle Income Countries, High Income Countries
}
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Equations
Change in Econ. Output per capita :∆Ŷr(t) = Ŷr(t)− Ŷr(t− 1) (C.55)




∆Ŷr(t) · F̂Dr(t− 1)
Ŷr(t− 1)
(C.56)




Global Demand for Food m :FDm(t) = σm · FD(t) (C.58)





Food Type m Waste :FWm(t) = δFm · FSm(t) (C.60)






Food Access for the Rich :FARICHr(t) = Ωr ·Qr(t) (C.62)









δm · FCm(t) (C.65)
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Target Food Production :F̃Dm(t) = γm · FD(t) (C.68)






Fish Production Capacity :FPFISH(t) = ζU · U(t) (C.70)
Change in Fisheries Stock :
dU(t)
dt
= UP (t)− FPFISH(t) (C.71)
Fisheries Replenishment :UP (t) = θU · U(t) (C.72)

















Change in Agricultural Land Stock :
dSm(t)
dt
= LPm(t)− LLm(t) (C.75)
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Agricultural Land GainLP (t) = θLm · Sm(t) (C.76)
Agricultural Land LossLL(t) = δLm · Sm(t) (C.77)
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Table C.7: Variables for Food Submodel
Variables Description Type
AFm Technology multiplier for food production type m Constant
FCm Consumption of food type m Endogenous
N̂Cij Nutrition consumption per capita by population group age i sex j Endogenous
F̂Ak Food access for socioeconomic group k Endogenous
F̂Dm Food demand per capita for food type m Endogenous
∆F̂Dm Change in food demand for food type m Endogenous
FD Global food demand for food type m Endogenous
FDm Food demand for food type m Endogenous
FPm Production of food type m Endogenous
FPFISH Production of fish Endogenous
FP Production capacity of food type m Endogenous
FPFISH Production capacity of fish Endogenous
F̃Pm Target production of food type m Endogenous
FSm Food stock for food type m Endogenous
FWm Food waste of food type m Endogenous
LCm Agricultural land loss of food type m due to other factors Endogenous
LLm Agricultural land loss of food type m due to climate change Endogenous
LPm Agricultural conversion of land food type m Endogenous
N̂R Food requirement per capita Constant
Pij Population group age i and sex j Endogenous
Qr Inequality in region r Endogenous
Sm Agricultural land area for food type m Endogenous
U Fisheries stock Endogenous
UP Fisheries replenishment Endogenous
W Water stock Endogenous
W̃Cm Desired consumption of water for food production of type m Endogenous
WDAm Agricultural water demand from food production of type m Endogenous
Ŷr Income per capita in region r Constant
∆Ŷr Change in income per capita in region r Constant
δL Fraction of agricultural land loss per year Constant
δFm Percentage of food type m that is wasted Constant
ϵm Income elasticity for demand of food type m Constant
ζU Fraction of fisheries that are accessible Constant
γm Nutritional conversion for food type m Constant
κm Speed of adjustment for price expectations of food type m Constant
ν1m Production elasticity for land inputs of food type m Constant
ν2m Production elasticity for water inputs of food type m Constant
θLm Fraction of agricultural land gained per year Constant
θU Fisheries replenishment rate Constant
σm Fraction of demand for food type m Constant
ξWm Fraction of freshwater supply dedicated to food production m Constant
Ωkr Inequality effect on food access for socioeconomic group k in region r Constant
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Figure D.1: General Health Access of Poor Population in High Income Region.
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Figure D.2: General Health Access of Rich Population in High Income Region.
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Figure D.3: Health Services in High Income Region.
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Figure D.4: Female Health Access in High Income Region.
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Figure D.5: Education Services in High Income Region.
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Figure D.6: General Health Access of Poor Population in Middle Income
Region.
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Figure D.7: General Health Access of Rich Population in Middle Income
Region.
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Figure D.8: Health Services in Middle Income Region.
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Figure D.9: Female Health Access in Middle Income Region.
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Figure D.10: Education Services in Middle Income Region.
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Figure D.11: Female Education Attainment in High Income Region.
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Figure D.12: Female Education Attainment in Middle Income Region.
207
APPENDIX D. CALIBRATION PLOTS FOR A HEALTH AND EDUCATION













































Figure D.13: General Health Access of Poor Population in Low Income Region.
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Figure D.14: General Health Access of Rich Population in Low Income Region.
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Figure D.15: Health Services in Low Income Region.
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Figure D.16: Female Health Access in Low Income Region.
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Figure D.17: Education Services in Low Income Region.
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Figure D.18: Female Education Attainment in Low Income Region.
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[58] A. E. Raftery, N. Li, H. Ševčı́ková, P. Gerland, and G. K. Heilig, “Bayesian
222
BIBLIOGRAPHY
probabilistic population projections for all countries,” Proceedings of the
National Academy of Sciences, vol. 109, no. 35, pp. 13 915–13 921, 2012.
[59] T. Dietz and E. A. Rosa, “Rethinking the environmental impacts of
population, affluence and technology,” Human ecology review, vol. 1,
no. 2, pp. 277–300, 1994.
[60] D. H. Meadows, D. L. Meadows, J. Randers, and W. W. Behrens, “The
limits to growth,” New York, vol. 102, 1972.
[61] H. S. Cole, Models of doom: A critique of the limits to growth. Universe
Pub, 1973.
[62] U. Bardi, “Criticism to “the limits to growth”,” in The Limits to Growth
Revisited. Springer, 2011, pp. 49–62.
[63] M. D. Mesarovic and E. C. Pestel, “A goal-seeking and regionalized model
for analysis of critical world relationships—the conceptual foundation,”
Kybernetes, vol. 1, no. 2, pp. 79–85, 1972.
[64] A. O. Herrera, H. D. Scolnik, G. Chichilnisky, G. C. Gallopin, and J. E.
Hardoy, Catastrophe or new society?: a Latin American world model.
IDRC, Ottawa, ON, CA, 1976.
[65] H. Linneman, J. d. Hoogh, M. A. Keyzer, H. D. Van Heemst et al., MOIRA:
Model of International Relations in Agriculture. Report of the project
223
BIBLIOGRAPHY
group” Food for a doubling world population”. North Holland Publishing
Comp., 1979.
[66] P. Roberts, “Sarum 76—a global modelling project,” Futures, vol. 9, no. 1,
pp. 3–16, 1977.
[67] A. Onishi, “Report on project fugi: future of global interdependence,” in
Fifth IIASA global modeling g conference. IIASA Laxenburg, Austria,
September 1977, 1977, pp. 1–183.
[68] W. Leontief, “Future of the world economy: a united nations study.[1980,
1990, and 2000],” 1977.
[69] W. D. Nordhaus, Managing the global commons: the economics of climate
change. MIT press Cambridge, MA, 1994, vol. 31.
[70] S. C. Peck and T. J. Teisberg, “Ceta: a model for carbon emissions
trajectory assessment,” The Energy Journal, pp. 55–77, 1992.
[71] A. Manne, R. Mendelsohn, and R. Richels, “Merge: A model for
evaluating regional and global effects of ghg reduction policies,” Energy
policy, vol. 23, no. 1, pp. 17–34, 1995.
[72] A. S. Manne, “Global 2100,” 1992.
[73] H. Dowlatabadi, “Integrated assessment models of climate change: An
incomplete overview,” Energy Policy, vol. 23, no. 4-5, pp. 289–296, 1995.
224
BIBLIOGRAPHY
[74] D. L. Kelly and C. D. Kolstad, “Integrated assessment models for climate
change control,” International yearbook of environmental and resource
economics, vol. 2000, pp. 171–197, 1999.
[75] S. Motesharrei, J. Rivas, and E. Kalnay, “Human and nature dynamics
(handy): Modeling inequality and use of resources in the collapse or
sustainability of societies,” Ecological Economics, vol. 101, pp. 90–102,
2014.
[76] T. S. Rowan, H. R. Maier, J. Connor, and G. C. Dandy, “An integrated
dynamic modeling framework for investigating the impact of climate
change and variability on irrigated agriculture,” Water Resources
Research, vol. 47, no. 7, 2011.
[77] J. Sterman, T. Fiddaman, T. Franck, A. Jones, S. McCauley, P. Rice,
E. Sawin, and L. Siegel, “Climate interactive: the c-roads climate policy
model,” System Dynamics Review, vol. 28, no. 3, pp. 295–305, 2012.
[78] J. Bongaarts, “A framework for analyzing the proximate determinants of
fertility,” Population and development review, pp. 105–132, 1978.
[79] ——, “Modeling the fertility impact of the proximate determinants: Time
for a tune-up,” Demographic Research, vol. 33, p. 535, 2015.
225
BIBLIOGRAPHY
[80] W. Lutz and K. Samir, “Global human capital: Integrating education and
population,” Science, vol. 333, no. 6042, pp. 587–592, 2011.
[81] L. J. Ralph and C. D. Brindis, “Access to reproductive healthcare for
adolescents: establishing healthy behaviors at a critical juncture in the
lifecourse,” Current opinion in obstetrics and gynecology, vol. 22, no. 5,
pp. 369–374, 2010.
[82] R. M. Barber, N. Fullman, R. J. Sorensen, T. Bollyky, M. McKee, E. Nolte,
A. A. Abajobir, K. H. Abate, C. Abbafati, K. M. Abbas et al., “Healthcare
access and quality index based on mortality from causes amenable to
personal health care in 195 countries and territories, 1990–2015: a novel
analysis from the global burden of disease study 2015,” The Lancet, vol.
390, no. 10091, pp. 231–266, 2017.
[83] T. Piketty, “About capital in the twenty-first century,” American
Economic Review, vol. 105, no. 5, pp. 48–53, 2015.
[84] J. Hansen, M. Sato, G. Russell, and P. Kharecha, “Climate sensitivity,
sea level and atmospheric carbon dioxide,” Phil. Trans. R. Soc. A, vol.
371, no. 2001, p. 20120294, 2013.
[85] G. Myhre, E. J. Highwood, K. P. Shine, and F. Stordal, “New estimates
of radiative forcing due to well mixed greenhouse gases,” Geophysical
research letters, vol. 25, no. 14, pp. 2715–2718, 1998.
226
BIBLIOGRAPHY
[86] M. A. Hanjra and M. E. Qureshi, “Global water crisis and future food
security in an era of climate change,” Food Policy, vol. 35, no. 5, pp. 365–
377, 2010.
[87] M. L. Parry, C. Rosenzweig, A. Iglesias, M. Livermore, and G. Fischer,
“Effects of climate change on global food production under sres emissions
and socio-economic scenarios,” Global Environmental Change, vol. 14,
no. 1, pp. 53–67, 2004.
[88] S. Solomon, G.-K. Plattner, R. Knutti, and P. Friedlingstein, “Irreversible
climate change due to carbon dioxide emissions,” Proceedings of the
national academy of sciences, pp. pnas–0 812 721 106, 2009.
[89] N. W. Arnell, “Climate change and global water resources,” Global
environmental change, vol. 9, pp. S31–S49, 1999.
[90] H. S. Houthakker, “An international comparison of household
expenditure patterns, commemorating the centenary of engel’s law,”
Econometrica, Journal of the Econometric Society, pp. 532–551, 1957.
[91] I. A. Shiklomanov, “Appraisal and assessment of world water resources,”
Water international, vol. 25, no. 1, pp. 11–32, 2000.
[92] L. Scrucca, “On some extensions to ga package: hybrid optimisation,
227
BIBLIOGRAPHY
parallelisation and islands evolution,” arXiv preprint arXiv:1605.01931,
2016.
[93] D. J. Bogue, G. Liegel, M. Kozloski et al., “Immigration, internal
migration, and local mobility in the us,” Books, 2009.
[94] R. Black, S. R. Bennett, S. M. Thomas, and J. R. Beddington, “Climate
change: Migration as adaptation,” Nature, vol. 478, no. 7370, pp. 447–
449, 2011.
[95] M. E. Hauer, J. M. Evans, and D. R. Mishra, “Millions projected to be at
risk from sea-level rise in the continental united states,” Nature Climate
Change, vol. 6, no. 7, pp. 691–695, 2016.
[96] M. E. Hauer, “Migration induced by sea-level rise could reshape the
us population landscape,” Nature Climate Change, vol. 7, pp. 321–325,
2017.
[97] D. Dodman, “Blaming cities for climate change? an analysis of urban
greenhouse gas emissions inventories,” Environment and urbanization,
vol. 21, no. 1, pp. 185–201, 2009.
[98] G. Marland, T. A. Boden, R. J. Andres, A. Brenkert, and C. Johnston,
“Global, regional, and national fossil fuel co2 emissions,” Trends: A
compendium of data on global change, pp. 34–43, 2003.
228
BIBLIOGRAPHY
[99] N. Y. Chan, K. L. Ebi, F. Smith, T. F. Wilson, and A. E. Smith, “An
integrated assessment framework for climate change and infectious
diseases.” Environmental Health Perspectives, vol. 107, no. 5, p. 329,
1999.
[100] Y. Barlas, “System dynamics: systemic feedback modeling for policy
analysis,” System, vol. 1, no. 59, 2007.
[101] P. Backlund, A. Janetos, D. Schimel et al., “The effects of climate change
on agriculture, land resources, water resources, and biodiversity in
the united states.” The effects of climate change on agriculture, land
resources, water resources, and biodiversity in the United States., 2008.
[102] U. Strasser, U. Vilsmaier, F. Prettenhaler, T. Marke, R. Steiger, A. Damm,
F. Hanzer, R. A. Wilcke, and J. Stötter, “Coupled component modelling for
inter-and transdisciplinary climate change impact research: Dimensions
of integration and examples of interface design,” Environmental
modelling & software, vol. 60, pp. 180–187, 2014.
[103] S. L. Cutter, L. Barnes, M. Berry, C. Burton, E. Evans, E. Tate, and
J. Webb, “A place-based model for understanding community resilience
to natural disasters,” Global environmental change, vol. 18, no. 4, pp.
598–606, 2008.
[104] J. M. Links, B. S. Schwartz, S. Lin, N. Kanarek, J. Mitrani-Reiser, T. K.
229
BIBLIOGRAPHY
Sell, C. R. Watson, D. Ward, C. Slemp, R. Burhans et al., “Copewell:
a conceptual framework and system dynamics model for predicting
community functioning and resilience after disasters,” Disaster medicine
and public health preparedness, vol. 12, no. 1, pp. 127–137, 2018.
[105] G. Luber and M. McGeehin, “Climate change and extreme heat events,”
American journal of preventive medicine, vol. 35, no. 5, pp. 429–435,
2008.
[106] G. A. Meehl and C. Tebaldi, “More intense, more frequent, and longer
lasting heat waves in the 21st century,” Science, vol. 305, no. 5686, pp.
994–997, 2004.
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